• Toll Free: +1- 844-445-2861
  •   sales@futuregenicreports.com

Pharmaceuticals

 
Global Cardiac Biomarkers Market Research Report 2018

This report studies the global Cardiac Biomarkers market status and forecast, categorizes the global Cardiac Biomarkers market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa.

Cardiovascular diseases are leading cause of morbidity and mortality globally. Biomarkers are generally used as an indicator forparticular diseases such as rheumatic and congenital heart diseases and cardiac arrhythmia. Cardiac biomarkers are measurable and quantifiable biological parameters. These are specifically used to check the presence or severity of cardiovascular diseases. Cardiac biomarkers are the substances that are released into blood when heart is damaged. These biomarkers are also used for diagnosing and monitoring diseases such as coronary syndrome or cardiac ischemia. The symptoms of these diseases includes chest pain, shortness of breath and nausea that ultimately leads to heart attack or angina. Cardiac biomarker tests helps to detect presence of coronary syndrome and cardiac ischemia to evaluate its severity and diagnosis.

The prevention of cardiac diseases by monitoring the heart conditions via cardiac biomarker testing is the profound approach for obtaining rapid results for immediate diagnosing and treatment. Cardiac biomarkers are protein-based traceable substances used as an indicator of biologic state and used for diagnostic and prognostic purposes associated with heart. Cardiac biomarkers are used as risk stratification for various cardiovascular diseases (CVDs), which include myocardial infraction, congestive heart failure, acute coronary syndrome (ACS) among others. The cardiac biomarkers that are widely used as an integrated diagnostic approach for CVDs include CK-MB, troponin I and T, myoglobin, BNPs, IMA and few others. Cardiac biomarkers market has witnessed a greater demand over the past five to six years.

There is a high demand for cardiac biomarkers due to their proficiency and the ability to provide accurate results. The number of clinical trials conducted for cardiac biomarkers is steadily increasing since manufactures, universities, and research institutes are focused on improving the efficiency and efficacy of the biomarkers. Cardiac biomarker manufacturers are increasingly focusing on R&D to perform several clinical trials to prove the effectiveness of the products and increase their consumer base. According to our industry research and analysis, the increase in number of clinical trials will be one of the key trends that will gain traction in the cardiac biomarkers market during the next few years.

North America leads the global market, owing to the high demand for cardiac testing, high CVD prevalence rate and growing awareness towards cardiac diagnostics solutions. Asia-Pacific is growing at the fastest CAGR due to the modernization, increasing disposable incomes and rising affordability for the advanced cardiac treatments.

The global Cardiac Biomarkers market is valued at xx million US$ in 2017 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2018-2025.

The major manufacturers covered in this report

Abbott
Alere
F. Hoffmann-La Roche
Advanced ImmunoChemical
AgPlus Diagnostics
BG Medicine
BioLegend
bioMérieux
Bio-Rad Laboratories
BODITECH MED

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering

North America
Europe
China
Japan
Southeast Asia
India

We can also provide the customized separate regional or country-level reports, for the following regions:

North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

Troponin
CK-MB
Natriuretic Peptides - BNP and NT-proBNP
Myoglobin
Others

On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including

Acute Coronary Syndrome
Myocardial Infarction
Congestive Heart Failure
Others

The study objectives of this report are:

To analyze and study the global Cardiac Biomarkers sales, value, status (2013-2017) and forecast (2018-2025).
Focuses on the key Cardiac Biomarkers manufacturers, to study the sales, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Cardiac Biomarkers are as follows:

History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Cardiac Biomarkers Manufacturers
Cardiac Biomarkers Distributors/Traders/Wholesalers
Cardiac Biomarkers Subcomponent Manufacturers
Industry Association
Downstream Vendors

Published

Read more
Global Cancer Biomarker Market Report, History and Forecast 2013-2025, Breakdown Data by Companies, Key Regions, Types and Application

This report studies the Cancer Biomarker market size by players, regions, product types and end industries, history data 2013-2017 and forecast data 2018-2025; This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

In 2017, the global Cancer Biomarker market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of between 2018 and 2025.

This report focuses on the global top players, covered

Abbott Laboratories
F.Hoffmann-La Roche Ltd.
QIAGEN
Thermo Fisher Scientific Inc.
Affymetrix Inc.
Illumina, Inc.
Agilent Technologies
Merck & Co. Inc.
Hologic, Inc.
Sino Biological Inc.
Becton, Dickinson and Company

Market segment by Regions/Countries, this report covers

North America
Europe
China
Rest of Asia Pacific
Central & South America
Middle East & Africa

Market segment by Type, the product can be split into

Genetic Biomarkers
Epigenetic Biomarkers
Metabolic Biomarkers
Proteomic Biomarkers
Others

Market segment by Application, the market can be split into

Drug discovery and Development
Diagnostics
Personalized medicine
Others

The study objectives of this report are:

To study and forecast the market size of Cancer Biomarker in global market.
To analyze the global key players, SWOT analysis, value and global market share for top players.
To define, describe and forecast the market by type, end use and region.
To analyze and compare the market status and forecast among global major regions.
To analyze the global key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Cancer Biomarker are as follows:

History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Raw material suppliers
Distributors/traders/wholesalers/suppliers
Regulatory bodies, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade associations and industry bodies
End-use industries

Published

Read more
Global Oral Oncology Drug Market Research Report 2017

In this report, the global Oral Oncology Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Oral Oncology Drug in these regions, from 2012 to 2022 (forecast), covering

North America
Europe
China
Japan
Southeast Asia
India

Global Oral Oncology Drug market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including

Roche
Eli Lilly
Celgene
Sanofi
eisai
Sumitomo Dainippon Pharma
Merck
Seattle Genetics
Takeda
Haosoh Pharma
Novartis
Pfizer

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

Cytotoxics
Targeted
Hormonals

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Oral Oncology Drug for each application, including

Breast?Cancer
Blood Cancer
Prostate?Cancer
Respiratory/Lung?Cancer
Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Published

Read more
Global Sterile Injectables Market Research Report 2018

In this report, the global Sterile Injectables market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Sterile Injectables in these regions, from 2013 to 2025 (forecast), covering

North America
Europe
China
Japan
Southeast Asia
India

Global Sterile Injectables market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including

Baxter International Inc.
Sanofi
Pfizer Inc.
GlaxoSmithKline plc.
AstraZeneca
GILEAD SCIENCES, INC.
Merck & Co., Inc.
Novartis AG
Johnson & Johnson Services, Inc.
Nova Nordisk A/S

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

By Molecule Type
Large Molecules
Small Molecules
By Drug Type
Monoclonal Antibodies (mAbs)
Cytokines
Insulin
Peptide Hormones
Vaccines
Immunoglobulins
Blood Factors
Peptide Antibiotics
Others

On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including

Cancer
Diabetes
Cardiovascular Diseases
Central Nervous Systems
Infectious Disorders
Musculoskeletal
Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Published

Read more
Global Generic Sterile Injectable Market Research Report 2018

This report studies the global Generic Sterile Injectable market status and forecast, categorizes the global Generic Sterile Injectable market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa.

The generic sterile injectable are FDA approved biologics that are used for the treatment of many diseases and disorders in the vast arena of the healthcare industry. The generic sterile injectable are very inexpensive as compared to that of their branded counterparts of these drugs and performs equally well. Thus, these Injectables are heavily in demand all the time and are used in majority of hospitals and clinics across the globe. However, due to the stringent FDA regulations for the production of these injectable, the rigorous demand satisfaction of these injectable has always been a constant challenge for the key players in the global generic sterile injectable market.

The generic sterile injectable market is expected to gain steady traction in the foreseeable future as the sterile injectable products find its application across a wide number of diseases and medical condition. Manufacturers are focused on increasing the production of generic sterile injectable to meet the rising demands without compromising on the quality of the injectable.

The global Generic Sterile Injectable market is valued at xx million US$ in 2017 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2018-2025.

The major manufacturers covered in this report

3M
Baxter Inc
Fresenius Kabi
Pfizer/Hospira
Novartis/Sandoz
Teva
Hikma
Sun Pharma
Dr. Reddy's
Mylan
AstraZeneca Plc
Merck & Co., Inc
Hellberg Safety Ab

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering

North America
Europe
China
Japan
Southeast Asia
India

We can also provide the customized separate regional or country-level reports, for the following regions:

North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

Monoclonal Antibodies
Cytokines
Insulin
Peptide Hormones
Vaccines
Others

On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including

Hospitals
Pharmacies
Online Pharmacies

The study objectives of this report are:

To analyze and study the global Generic Sterile Injectable sales, value, status (2013-2017) and forecast (2018-2025).
Focuses on the key Generic Sterile Injectable manufacturers, to study the sales, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Generic Sterile Injectable are as follows:

History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Generic Sterile Injectable Manufacturers
Generic Sterile Injectable Distributors/Traders/Wholesalers
Generic Sterile Injectable Subcomponent Manufacturers
Industry Association
Downstream Vendors

Published

Read more
Global Gastrointestinal OTC Drugs Market Research Report 2018

This report studies the global Gastrointestinal OTC Drugs market status and forecast, categorizes the global Gastrointestinal OTC Drugs market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa.

In 2017, the global Gastrointestinal OTC Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx.x % between 2018 and 2025.

The major manufacturers covered in this report
Bayer
GlaxoSmithKline
Johnson & Johnson
Pfizer
Perrigo
Abbott
C.B. Fleet
Purdue Pharma
Teva Pharmaceutical
Sanofi
Boehringer Ingelheim
Xiuzheng Pharmaceutical Group
China Resources Sanjiu Medical & Pharmaceutical
Harbin Pharmaceutical Group
JZJT
Tongrentang (TRT)

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering
North America
Europe
Asia-Pacific
South America
Middle East & Africa

The regional scope of the study is as follows:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Capsule
Tablet
Others
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

The study objectives of this report are:
To analyze and study the global Gastrointestinal OTC Drugs sales, value, status (2013-2017) and forecast (2018-2025).
Focuses on the key Gastrointestinal OTC Drugs manufacturers, to study the sales, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Gastrointestinal OTC Drugs are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Gastrointestinal OTC Drugs Manufacturers
Gastrointestinal OTC Drugs Distributors/Traders/Wholesalers
Gastrointestinal OTC Drugs Subcomponent Manufacturers
Industry Association
Downstream Vendors

Published

Read more
Global e-Pharma Market Report, History and Forecast 2013-2025, Breakdown Data by Manufacturers, Key Regions, Types and Application

This report studies the e-Pharma market size (value and volume) by players, regions, product types and end industries, history data 2013-2017 and forecast data 2018-2025; This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

ePharma is a long-standing platform known to spark insightful conversations and inspire through instructional case studies, out-of-industry perspectives, and leading-edge technology, providing attendees with strategies and tactics to grow as leaders, embrace disruption, and seize innovation in the evolving pharma and healthcare landscape.

Increased internet penetration across the world, improved healthcare infrastructure, rapid aging of the population, and increasing awareness pertaining to ecommerce amongst users are some of the factors propelling growth. Shift in consumer behavior with an increased demand for convenience is also one of the key factors contributing to the market growth. Furthermore, rising adoption of ecommerce and digital technologies in healthcare sector is expected to propel growth.

The global e-Pharma market was xx million US$ in 2017 and is expected to xx million US$ by the end of 2025, growing at a CAGR of xx% between 2018 and 2025.

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of e-Pharma in these regions, from 2013 to 2025, covering

North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia and Turkey etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil etc.)
Middle East and Africa (Egypt and GCC Countries)

The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in this market include

Kroger
Walgreens
Giant Eagle
Walmart
Express Scripts
CVS Health
Optum Rx
Rowlands Pharmacy
Zur Rose Group

By the product type, the market is primarily split into

Pharmacy benefit manager
Legitimate Internet pharmacy
Illegal or unethical internet pharmacy

By the end users/application, this report covers the following segments

Hospitals
Personal use
Government research

We can also provide the customized separate regional or country-level reports, for the following regions:

North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
Rest of Middle East & Africa

The study objectives of this report are:

To study and analyze the global e-Pharma market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of e-Pharma market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global e-Pharma manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the e-Pharma with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of e-Pharma submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of e-Pharma are as follows:

History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million USD) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of e-Pharma market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Raw material suppliers
Distributors/traders/wholesalers/suppliers
Regulatory bodies, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade associations and industry bodies
End-use industries

Published

Read more
Global Topical Pain Relief Market Size, Status and Forecast 2018-2025

This report focuses on the global Topical Pain Relief status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Topical Pain Relief development in United States, Europe and China.

Pain is a distressing feeling which is usually caused by intense or damaging stimuli. Pain is most prevalent symptom associated with most of chronic conditions. Pain management involves the employment of medications or analgesics and therapies to treat several pain conditions. Whenever, these medications are applied directly to the skin they are known as topical pain relief.

The growth of the global topical pain relief market is majorly driven by increase in prevalence of arthritis and other bone-related conditions, diabetic neuropathy, cancer, leading to pain. Other factors boosting the market growth include rise in adoption of topical pain relief products as they cause lesser side effects as compared to oral pain relief, upsurge in geriatric population across the world, and increase in demand for topical pain relief by sports players.

In 2017, the global Topical Pain Relief market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.

The key players covered in this study

Johnson & Johnson
Novartis AG
GlaxoSmithKline Plc.
Pfizer Inc.
Reckitt Benckiser Group Plc.
Sanofi S.A.
Topical BioMedics
AdvaCare Pharma
Sun Pharmaceutical Industries Ltd.
Nestle S.A.

Market segment by Type, the product can be split into

Non-Opioids
Opioids

Market segment by Application, split into

Pharmacies & Drug Stores
e-Commerce
Retail & Grocery Stores

Market segment by Regions/Countries, this report covers

United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:

To analyze global Topical Pain Relief status, future forecast, growth opportunity, key market and key players.
To present the Topical Pain Relief development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Topical Pain Relief are as follows:

History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Published

Read more
Global Diabetes Drugs Market Research Report 2018

This report studies the global Diabetes Drugs market status and forecast, categorizes the global Diabetes Drugs market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa.

The global Diabetes Drugs market is valued at xx million US$ in 2017 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2018-2025.

The major manufacturers covered in this report

Novo Nordisk(US)
Sanofi(DE)
Merck
Eli Lilly(UK)
AstraZeneca
Boehringer Ingelheim
Novartis(US)
Johnson & Johnson
Takeda
Bayer
HUADONG MEDICINE(DE)
Kelun(US)
NCPC(US)
Wanbang(IT)
Hisun(DE)
Yiling(US)
Gan & Lee(US)
Dongbao(IT)
JUMCAN(SK)
Taloph(US)

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering

North America
Europe
China
Japan
Southeast Asia
India

We can also provide the customized separate regional or country-level reports, for the following regions:

North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

Injection
Oral
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
Type 1 Diabetes
Type 2 Diabetes

The study objectives of this report are:
To analyze and study the global Diabetes Drugs sales, value, status (2013-2017) and forecast (2018-2025).
Focuses on the key Diabetes Drugs manufacturers, to study the sales, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Diabetes Drugs are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Diabetes Drugs Manufacturers
Diabetes Drugs Distributors/Traders/Wholesalers
Diabetes Drugs Subcomponent Manufacturers
Industry Association
Downstream Vendors

Published

Read more
Global Lymphoma Drugs Market Professional Survey Report 2018

This report studies the global Lymphoma Drugs market status and forecast, categorizes the global Lymphoma Drugs market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, India, Southeast Asia and other regions (Central & South America, and Middle East & Africa).

Lymphoma is a type of cancer that affects the immune system of the body.

According to the report, one of the major drivers for this market is increase in industry-academia collaborations.
The global Lymphoma Drugs market is valued at xx million US$ in 2017 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2018-2025.

The major manufacturers covered in this report

Celgene
F. Hoffmann-La Roche
Johnson & Johnson
Seattle Genetics
Amgen
Bristol-Myers Squibb
Gilead Sciences
GlaxoSmithKline
Novartis
Pfizer

Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering

North America
Europe
China
Japan
India
Southeast Asia
Other regions (Central & South America, Middle East & Africa)

We can also provide the customized separate regional or country-level reports, for the following regions:

North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

HL
NHL

By Application, the market can be split into

Hospitals
Ambulatory Surgical Centers

The study objectives of this report are:

To analyze and study the global Lymphoma Drugs capacity, production, value, consumption, status (2013-2017) and forecast (2018-2025);
Focuses on the key Lymphoma Drugs manufacturers, to study the capacity, production, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Lymphoma Drugs are as follows:

History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Lymphoma Drugs Manufacturers
Lymphoma Drugs Distributors/Traders/Wholesalers
Lymphoma Drugs Subcomponent Manufacturers
Industry Association
Downstream Vendors

Published

Read more
Global Lupus Therapeutic Market Professional Survey Report 2018

This report studies the global Lupus Therapeutic market status and forecast, categorizes the global Lupus Therapeutic market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, India, Southeast Asia and other regions (Central & South America, and Middle East & Africa).

Systemic lupus erythematosus (SLE) is an autoimmune disease that causes a chronic inflammatory condition.
According to the report, one of the major drivers for this market is high prevalence rate.

The global Lupus Therapeutic market is valued at xx million US$ in 2017 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2018-2025.

The major manufacturers covered in this report
F.Hoffmann-La Roche
GlaxoSmithKline
Medlmmune
Pfizer
ADMA Biologics
Amgen
Anthera Pharmaceuticals
Bayer HealthCare
Biogen

Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering

North America
Europe
China
Japan
India
Southeast Asia
Other regions (Central & South America, Middle East & Africa)

We can also provide the customized separate regional or country-level reports, for the following regions:

North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type,
primarily split into
B-Cell Modulators
T-Cell Modulators
Immunosuppressive And Cytotoxic Drugs
Proinflammatory And Cytokine Inhibitors
Others

By Application, the market can be split into

Clinics
Hospitals
Physicians' Office Laboratories

The study objectives of this report are:

To analyze and study the global Lupus Therapeutic capacity, production, value, consumption, status (2013-2017) and forecast (2018-2025);
Focuses on the key Lupus Therapeutic manufacturers, to study the capacity, production, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Lupus Therapeutic are as follows:

History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Lupus Therapeutic Manufacturers
Lupus Therapeutic Distributors/Traders/Wholesalers
Lupus Therapeutic Subcomponent Manufacturers
Industry Association
Downstream VendorsAA

Published

Read more
Global Marine Pharmaceuticals Market Insights, Forecast to 2025

This report studies the global market size of Marine Pharmaceuticals in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Marine Pharmaceuticals in these regions.

This research report categorizes the global Marine Pharmaceuticals market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

The vendors in the global marine pharmaceuticals market have been entering into licensing agreements continuously. The licensing agreements in the marine pharmaceuticals market allow the company to expand the reach of the product to multiple nations with relatively less involvement and risk. These licensing agreements will assist in increasing the availability of marine pharmaceuticals across the regions and will help the global marine pharmaceuticals market to grow during the forecast period.

The licensing agreements are a major factor driving the market's growth.

In 2017, the global Marine Pharmaceuticals market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, segment, and project the size of the Marine Pharmaceuticals market based on company, product type, application and key regions.

The various contributors involved in the value chain of Marine Pharmaceuticals include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Marine Pharmaceuticals include

Abbott Laboratories
AbbVie
Alkermes
Amarin
Amgen
Amnis
Aphios
Array BioPharma
Associates Of Cape Cod
Astex Pharmaceuticals
AstraZeneca
ASYMPTOTE
Bayer
BioMarin Pharmaceutical
Biotest
Bristol-Myers Squibb
Cardax

Market Size Split by Type

Phenol
Steroid
Ether
Peptide

Market Size Split by Application

Anti-Microbial
Anti-Tumour
Anti-Cardiovascular
Anti-Viral
Anti-Inflammatory
Others

Market size split by Region

North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:

To study and analyze the global Marine Pharmaceuticals market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.

To understand the structure of Marine Pharmaceuticals market by identifying its various subsegments.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

Focuses on the key global Marine Pharmaceuticals manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

To analyze the Marine Pharmaceuticals with respect to individual growth trends, future prospects, and their contribution to the total market.

To project the value and volume of Marine Pharmaceuticals submarkets, with respect to key regions (along with their respective key countries).

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Marine Pharmaceuticals are as follows:

History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Marine Pharmaceuticals market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Published

Read more
Global Fenofibrate Market Research Report 2017

This report studies Fenofibrate in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering

Abbott Laboratories
Solvay
SKYEPHARMA
Shionogi
Lupin Pharmaceuticals
TEVA
IMPAX LABS
RANBAXY LABORATORIES
VALEANT INTL
MYLAN PHARMS
ETHYPHARM
Zhongsheng Pharmacy
Piom
Xinyi
Asen Pharm
Jingxin Pharm

Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Fenofibrate in these regions, from 2011 to 2021 (forecast), like

North America
Europe
China
Japan
Southeast Asia
India

Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into

Type I
Type II

Split by application, this report focuses on consumption, market share and growth rate of Fenofibrate in each application, can be divided into

Application 1
Application 2

Published

Read more
Global Oral Controlled Drug Delivery System Market Report, History and Forecast 2013-2025, Breakdown Data by Manufacturers, Key Regions, Types and Application

This report studies the Oral Controlled Drug Delivery System market size (value and volume) by players, regions, product types and end industries, history data 2013-2017 and forecast data 2018-2025; This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

The global Oral Controlled Drug Delivery System market was million US$ in 2017 and is expected to million US$ by the end of 2025, growing at a CAGR of between 2018 and 2025.

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Oral Controlled Drug Delivery System in these regions, from 2013 to 2025, covering

North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia and Turkey etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil etc.)
Middle East and Africa (Egypt and GCC Countries)

The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in this market include

AstraZeneca Plc.
Mylan N.V.
Sanofi
F. Hoffman-La-Roche Ltd.
Bristol-Myers Squibb Company
Sun Pharmaceuticals Industries Ltd
Abbott Laboratories
Merck & Co. Inc.
Novartis AG
Pfizer Inc.
Vectura Group plc.
GlaxoSmithKline plc.
Johnson & Johnson Services, Inc.
By the product type, the market is primarily split into
Diffusion Controlled Release System
Dissolution Controlled Release System
Ion Exchange Resins Controlled Release
Hydro-dynamically Balanced Drug Delivery System
Osmotically Controlled Release System
Dissolution & Diffusion Controlled Release System

By the end users/application, this report covers the following segments

Hospitals
Clinics
Other

We can also provide the customized separate regional or country-level reports, for the following regions:

North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
Rest of Middle East & Africa

The study objectives of this report are:

To study and analyze the global Oral Controlled Drug Delivery System market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.

To understand the structure of Oral Controlled Drug Delivery System market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

Focuses on the key global Oral Controlled Drug Delivery System manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Oral Controlled Drug Delivery System with respect to individual growth trends, future prospects, and their contribution to the total market.

To project the value and volume of Oral Controlled Drug Delivery System submarkets, with respect to key regions (along with their respective key countries).

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Oral Controlled Drug Delivery System are as follows:

History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million USD) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Oral Controlled Drug Delivery System market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders

Raw material suppliers
Distributors/traders/wholesalers/suppliers
Regulatory bodies, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade associations and industry bodies
End-use industries

Available Customizations

With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:

Further breakdown of Oral Controlled Drug Delivery System market on basis of the key contributing countries.
Detailed analysis and profiling of additional market players.

Published

Read more
Global IQF Products Market Analysis 2012-2017 and Forecast 2018-2023

Individual quick freezing (IQF) is one of the major technology used to keep variety of fruits, vegetables, meat, poultry and sea food products fresh for longer duration and to streamline the supply chain of these with rare chances of loss or damage to the stored products. IQF or individual quick freezing is the process of quickly freezing each unit of product separately, by using cold air that is blown at a high speed on a fluidized bed. Products that are frozen using IQF technology have better flavor, texture and are more nutritious than product frozen with different methods.

The global IQF Products market will reach xxx Million USD in 2018 and CAGR xx% 2018-2023. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of IQF Products by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
IQF Fruits
IQF Vegetables
IQF Seafood
IQF Poultry

Company Coverage (Sales Revenue, Price, Gross Margin, Main Products etc.):
Superior Foods Companies
SunOpta
Simplot
Titan Frozen Fruit
Gaotai
Jinyuan Agriculture
Junao
SCELTA
California Garlic Company
Eurial
Oxford Frozen Foods

Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Direct Consumption
Processing Consumption

Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)"
 

Published

Read more
Global Overactive Bladder Treatment Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

Description
Overactive bladder (OAB) is a bladder disorder that results in an abnormal urge to urinate, urinary frequency, and nocturia (voiding at night). Some patients may also experience urinary incontinence (involuntary loss of bladder control).

Scope of the Report:
This report focuses on the Overactive Bladder Treatment in global market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, types and applications.
Market Segment by Manufacturers, this report covers 
    Allergan
    Astellas Pharma
    Pfizer
    Johnson & Johnson 
    Teva (Actavis)

Market Segment by Regions, regional analysis covers 
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia and Italy)
    Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
    South America (Brazil, Argentina, Colombia)
    Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
    Anticholinergics
    Mirabegron
    Botox
    Other Drugs

Market Segment by Applications, can be divided into
    Idiopathic Overactive Bladder
    Neurogenic Overactive Bladder

There are 15 Chapters to deeply display the global Overactive Bladder Treatment market.

Chapter 1, to describe Overactive Bladder Treatment Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Overactive Bladder Treatment, with sales, revenue, and price of Overactive Bladder Treatment, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Overactive Bladder Treatment, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the key regions, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Overactive Bladder Treatment market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Overactive Bladder Treatment sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Published

Read more
Global Meningococcal Vaccine Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

"Meningococcal vaccine refers to any of the vaccines used to prevent infection by Neisseria meningitides. The vaccines are between 85 and 100% effective for at least two years. They result in a decrease in meningitis and sepsis among populations where they are widely used. They are given either by injection into a muscle or just under the skin.

Scope of the Report:
This report focuses on the Meningococcal Vaccine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Top-down and bottom-up approaches are used to validate the global Meningococcal Vaccinesize market and estimate the market size for manufacturers, regions segments, product segments and applications.

The market estimations in this report are based on the marketed sale price of Meningococcal Vaccine. The percentage splits, Market Share, and breakdowns of the product segments are derived on the basis of weightages assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Meningococcal Vaccine market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.

Major players in the market are identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top manufacturers; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, Market Share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYR Pharma & Healthcare Research Center and presented in this report.

The worldwide market for Meningococcal Vaccine is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers
Novartis
GSK
Merck
CSL
Baxter
JN International Medical Corporation
Serum Institute of India
Bio-Med
China National Biotec Group
Hualan Bio
Walvax
Zhifei

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Quadrivalent
Bivalent
Others

Market Segment by Applications, can be divided into
Pneumonia
Meningitis
Bacteremia
Others (Arthritis, Conjunctivitis, Urethritis)
 

Published

Read more
Global Moxifloxacin HCl Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

"Moxifloxacin hydrochloride (moxifloxacin HCl) is used to treat a variety of bacterial infections. Moxifloxacin HCl is a broad-spectrum fourth generation fluoroquinolone antibiotic. These antibiotics prevent unwinding of double-stranded DNA by binding DNA gyrase or DNA topoisomerase. By preventing the formation of single-stranded DNA, inhibit bacterial replication.

Scope of the Report:
This report focuses on the Moxifloxacin HCl in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The report provides key statistics on the market status of the Moxifloxacin HCl manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.

Firstly, the report provides a basic overview of the industry including its definition, applications and manufacturing technology. Then, the report explores the international and Chinese major industry players in detail. In this part, the report presents the company profile, product specifications, capacity, production value, and 2013-2018 market shares for each company. Through the statistical analysis, the report depicts the global and Chinese total market of Moxifloxacin HCl industry including capacity, production, production value, cost/profit, supply/demand and Chinese import/export. The total market is further divided by company, by country, and by application/type for the competitive landscape analysis.

The report then estimates the market development trends of Moxifloxacin HCl industry. Analysis of upstream raw materials, downstream demand, and current market dynamics is also carried out. In the end, the report makes some important proposals for a new project of Moxifloxacin HCl Industry before evaluating its feasibility. Overall, the report provides an in-depth insight of Moxifloxacin HCl industry covering all important parameters.

In the end, the report makes some important proposals for a new project of Moxifloxacin Hydrochloride Tablets Industry before evaluating its feasibility.
The worldwide market for Moxifloxacin HCl is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers
Bayer
Rivopharm
Actavis UK
MERCK
Cayman
Allergan
Tecoland
BOC Sciences
Aurobindo
NIVIKA Chemo Pharma

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
98.0%-99.5%
99.5-99.9%
≥ 99.9%

Market Segment by Applications, can be divided into
Oral tablets
Injection
Ophthalmic drugs
 

Published

Read more
Global Remifentanil Hydrochloride Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

"Remifentanil Hydrochloride (also named Ultiva) is a kind of white to off-white crystalline powder or crystals that used to maintain analgesia and anesthesia induction of general anesthesia. Remifentanil Hydrochloride is freely soluble in water, sparingly soluble in ethanol, slightly soluble in isopropyl alcohol and very slightly soluble in methyl isobutyl ketone.
Remifentanil Hydrochloride should be administered only in a setting fully equipped for the monitoring and support of respiratory and cardiovascular function and by persons specifically trained in the use of anaesthetic drugs and the recognition and management of the expected adverse effects of potent opioids, including respiratory and cardiac resuscitation. Such training must include the establishment and maintenance of a patent airway and assisted ventilation.

Scope of the Report:
This report focuses on the Remifentanil Hydrochloride in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Remifentanil Hydrochloride is a kind of high-end opioid analgesic, it can used in the maintain analgesia and anesthesia induction of general anesthesia, it has the feature of working fast, no accumulate in the body, blood and drug concentration smooth, short duration of action, strong analgesic potency, recover quickly after using, light adverse reactions and so on.

The global remifentanil hydrochloride company mainly concentrates in the developed countries, the consumption groups also concentrate in the developed countries and the high income people.

The Europe remifentanil hydrochloride industry is mainly concentrated in the UK and Germany, it has a high degree of industrial concentration, it is mainly due to the patent and the technology monopoly, the UK and Germany has the highest production and consumption, the consumption groups are mainly higher income levels due to the high price.

The remifentanil hydrochloride is produced in the developed countries, so the import and export are between developing countries and developed countries. The remifentanil hydrochloride has relative high growth rate and the gross margin is about 80%.

The worldwide market for Remifentanil Hydrochloride is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers
GSK
Macfarlan Smith
Abbott
Mylan
Arevipharma
AMRI

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
1mg/Pcs
2mg/Pcs
5mg/Pcs

Market Segment by Applications, can be divided into
Endotracheal intubation operation
Neurosurgery
Outpatient surgery
Postoperative analgesia
Other
 

Published

Read more
Global Liraglutide Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

"Liraglutide (NN2211) is a long-acting glucagon-like peptide-1 receptor agonist, binding to the same receptors as does the endogenous metabolic hormone GLP-1 that stimulates insulin secretion. Marketed under the brand name Victoza, it is an injectable drug developed by Novo Nordisk for the treatment of type 2 diabetes. In 2015, Novo Nordisk began marketing it in the U.S. under the brand name Saxenda as a treatment for obesity in adults with at least one weight-related comorbid condition.

Scope of the Report:
This report focuses on the Liraglutide in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The total amount of Patents about Liraglutide are 1871, among those Patents, 44%is about application, 26%is about Combination therapy, and 12%is about Preparation method.
In these patents, accounting for Europe is the largest, followed by North America, and finally Asia.
The application of Liraglutide
Liraglutide for the treatment of type 2 diabetes mellitus
Liraglutide 1.2 mg daily in triple therapy regimens (in combination with metformin and a sulphonylurea, or metformin and a thiazolidinedione) is recommended as an option for the treatment of people with type 2 diabetes, only if used as described for exenatide in 'Type 2 diabetes: the management of type 2 diabetes'
Liraglutide 1.2 mg daily in dual therapy regimens (in combination with metformin or a sulphonylurea) is recommended as an option for the treatment of people with type 2 diabetes, only if the person is intolerant of either metformin or a sulphonylurea, or treatment with metformin or a sulphonylurea is contraindicated, and the person is intolerant of thiazolidinediones and dipeptidyl peptidase-4 (DPP-4) inhibitors, or treatment with thiazolidinediones and DPP-4 inhibitors is contraindicated.
Liraglutide 1.8 mg daily is not recommended for the treatment of people with type 2 diabetes.
The Committee concluded that the evidence provided was not robust enough to allow it to recommend liraglutide as a cost-effective alternative to either thiazolidinediones or DPP-4 inhibitors as a triple therapy regimen, however it believes liraglutide is a cost-effective treatment option relative to exenatide.

Taking into account the lack of clinical trial evidence showing a significant benefit from increasing the liraglutide dose from 1.2 mg to 1.8 mg, the widely varying ICERs and the uncertainty in the economic analysis, the Committee was unable to recommend liraglutide 1.8 mg for the treatment of type 2 diabetes.
The Committee concluded that people with type 2 diabetes currently receiving liraglutide who do not meet the criteria specified in section 1.1 or 1.3, or who are receiving liraglutide 1.8 mg, should have the option to continue their current treatment until they and their clinicians consider it appropriate to stop.

The worldwide market for Liraglutide is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers
HEC Pharm
Bachem
Bharat Pharmaceuticals
Kingpep Biotechnology
Shenzhen JYMed Technology
Wuxi Asiapeptide
AmbioPharm

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Pills
Liquid

Market Segment by Applications, can be divided into
Hospital
Drug Store
 

Published

Read more
Global Anti-Peptic Ulcer Drugs Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

"Anti-peptic Ulcre drug is one of various classes of drugs with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract.

Scope of the Report:
This report focuses on the Anti-Peptic Ulcer Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
China’s anti-trust crackdown on foreign pharmaceutical companies has left many foreign investors in the healthcare industry shocked. The Chinese government has had no qualms about openly stating that it prefers hospitals to purchase from domestic producers. That said, China’s homegrown manufacturers of medical devices and medicine still lack the sophistication to produce many of the more advanced health care products the country needs. Amid rising living standards and an aging population, China’s healthcare needs are set to rise sharply in the coming years.
In April 2015, China amended its Drug Administration Law, introducing two major changes.
The first is a simplification of the company set-up procedure for pharmaceutical companies. Prior to the amendment, investors that wanted to manufacture or distribute pharmaceuticals needed to have a Drug Manufacturing License or a Drug Distribution License before applying for a business license. Now, investors may apply for these after the company has been set up, significantly speeding up the incorporation process.

More importantly, the amendment removes the price controls that the Chinese government had in place for medicines. As of the year 2000, medicines that were listed on the government’s Medical Insurance Catalog, and those medicines on which there was a monopoly, had their prices fixed or guided by the government. About 23 percent of the medicines on the Chinese market had government fixed or guided prices. The price of other medicines was left to market forces. While these price restrictions are now fully removed, companies still need to abide by China’s anti-trust laws. Companies abusing their dominant market position are still punishable under Chinese law.
While recent moves have made it easier for foreign investors to introduce new medical products to the Chinese market, the Chinese government has at the same time placed restraints on advertising healthcare products. The final text of the revised Advertising Law was released by the National People’s Congress, China main legislative body, in late April 2015. The law comes into force in September 2015.

The 2015 Advertising Law has special stipulations about advertising for medicine and medical devices. For one, advertising for anesthetics, psychotropic drugs, toxic and radioactive drugs for medical use is not allowed, nor is advertisement for drugs, treatment plans and medical devices to combat drug addiction. Advertising for prescription drugs other than those mentioned previously is only allowed in professional medical journals.

The content for medical advertisements is regulated as well. Any advertisement for drugs, medical treatment or medical devices may not contain the following:


The worldwide market for Anti-Peptic Ulcer Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers
AstraZeneca
Ask-pharm
Takeda
Yangtze River Pharm
Shandong Luoxin
Huadong Medicine
Changzhou Siyao
Beijing Yuekang
Guangdong Dahua
Xian Janssen

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Proton Pump Inhibitors (PPIs)
Potassium-Competitive Acid Blockers (P-CAB)
Antacids
H2 Antagonists
Ulcer Protective Drugs

Market Segment by Applications, can be divided into
Gastritis
Gastric Ulcers
Duodenal Ulcers
Gastroesophageal Reflux Disease (GERD)
 

Published

Read more
Global Pediatric Healthcare Market by Manufacturers, Regions, Type and Application, Forecast to 2023

"Pediatrics is the branch of medicine that deals with the medical care of infants and children, the age limit usually ranges from birth up to 7 years of age. Correspondingly, it is obvious that pediatric healthcare mainly involves in nutritionals, vaccines and drugs, all of which the purpose is to help children to grow up healthily. Millions of pedia die from disease, malnutrition and virus each year, as a consequence, it is quite significant to study pediatric healthcare.

Scope of the Report:
This report focuses on the Pediatric Healthcare in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
At present, in the foreign industrial developed countries the Pediatric Healthcare industry is generally at a more advanced level, the world's large enterprises are mainly concentrated in USA and Europe. Meanwhile, foreign companies have more advanced equipment, strong R & D capability, the technical level is in a leading position.
Although sales of pediatric healthcare brought a lot of opportunities, for the new entrants with only advantage in capital without sufficient support in technology and downstream channels, the research group did not recommend taking risk to enter this market.

The worldwide market for Pediatric Healthcare is expected to grow at a CAGR of roughly 3.8% over the next five years, will reach 149300 million US$ in 2023, from 119700 million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers
Abbott
AstraZeneca
GlaxoSmithKline
Merck & Co.
Pfizer
Sanofi
Perrigo
Mead Johnson
Nestlé
Danone

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Vaccines
Drugs
Nutritionals

Market Segment by Applications, can be divided into
Prophylactic Products
Therapeutic Products

Published

Read more
Global Biologics and Biosimilars Market by Manufacturers, Regions, Type and Application, Forecast to 2023

"A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a vaccine.

Scope of the Report:
This report focuses on the Biologics and Biosimilars in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Most of biologics manufacturer are concentrated in US, Germany,UK and other developed countries. But in biosimilars industry the situation is different, manufacturer in developing countries play a very important role.
Through the research we tend to believe that the growth of biologics industry maybe slow but high profits during the period of patent may attractive. As to biosimilars, now is a changce for newcomers and they will greatly change the industry.

The worldwide market for Biologics and Biosimilars is expected to grow at a CAGR of roughly 5.5% over the next five years, will reach 199600 million US$ in 2023, from 144700 million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers
Roche
Amgen
AbbVie
Sanofi-Aventis
Johnson & Johnson
Pfizer
Novo Nordisk
Eli Lilly
Novartis
Merck
3sbio
Changchun High Tech
CP Guojian
Biotech
Gelgen
Innovent
Dong Bao
Ganlee
United Laboratories
Others

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Antibody
Hormone
Growth Factors
Other

Market Segment by Applications, can be divided into
Tumor
Diabetes
Cardiovascular
Hemophilia
Other
 

Published

Read more
Global Pneumococcal Vaccine Market by Manufacturers, Regions, Type and Application, Forecast to 2023

"Pneumococcal Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria.

Scope of the Report:
This report focuses on the Pneumococcal Vaccine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
North America is the largest consumption market of Pneumococcal Vaccine with sales market share nearly 40% in 2015.
The second place is Europe, following North America with sales market share over 18% in 2016. Asia-Pacific is another important market of Pneumococcal Vaccine, enjoy nearly 16% sales market share in 2013, but the consumption experienced a sharp decrease due to approval of government departments in last few years.

The worldwide market for Pneumococcal Vaccine is expected to grow at a CAGR of roughly 1.0% over the next five years, will reach 7580 million US$ in 2023, from 7140 million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers
Pfizer
GSK
MSD
Sanofipasteur
CDIBP

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
PPSV 23
PCV 7/13
PCV 10

Market Segment by Applications, can be divided into
Child
Adult

Published

Read more
Global Photocatalyst Market by Manufacturers, Regions, Type and Application, Forecast to 2023

"The word Photocatalyst is a composite word which is composed of two parts, “photo” and “catalysis”. Photocatalysts are defined as substances that promote reactions by absorbing light without being altered themselves, before or after the reaction. There are various materials that show photocatalytic capability, and titanium dioxide is said to be the most effective.

Scope of the Report:
This report focuses on the Photocatalyst in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The worldwide market for Photocatalyst is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers
TOTO
Showa Denko
ISK
BASF
JSR CORP.
KRONOS
KHI
Lister
Aoinn Environmental
Dongguan Tomorrow
Chem-Well Tech
Kon Corporation

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
TiO2 Base
ZnO Base
SnO2 Base
ZrO2 Base

Market Segment by Applications, can be divided into
Products for Everyday Life
Cleaning Equipment
Road Materials
Interior Materials
Exterior Materials

Published

Read more
Global First Aid Kit Market by Manufacturers, Regions, Type and Application, Forecast to 2023

"A first aid kit is a collection of supplies and equipment for use in giving first aid, and can be put together for the purpose by an individual or organization or purchased complete. There is a wide variation in the contents of first aid kits based on the knowledge and experience of those putting it together, the differing first aid requirements of the area where it may be used and variations in legislation or regulation in a given area.

Scope of the Report:
This report focuses on the First Aid Kit in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
As an useful and convenient tool needed in emergency, first aid kit are widely produced and sold worldwide, especially in developed countries such as United States, Japan, Germany and etc. Currently, Europe is the largest consumption market of first aid kit worldwide, driven by the wide awareness of the necessity of having a first aid kit at home or when going outside. Consumption market of first aid kit in United States and Japan are also quite remarkable. However, market in these regions is already mature, and doesn’t grow that fast any longer. Consumption market in developing countries and regions are regarded as emerging market of first aid kit and the main market growth driven factor in the following decade.
In summary, there is still market space of first aid kit, especially in emerging market; and the market is still promising to some extent. But it is suggested that new enterprises should not enter the market without technology or marketing channel advantages.

The worldwide market for First Aid Kit is expected to grow at a CAGR of roughly 4.8% over the next five years, will reach 370 million US$ in 2023, from 280 million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers
Acme United
Johnson & Johnson
3M
ZEE
Certified Safety
Cintas
REI
Lifeline
Honeywell
Tender
St John
Beiersdorf
Hartmann
Safety First Aid
Lifesystems
First Aid Holdings
Firstar
KANGLIDI
Yunnan Baiyao
Longbow

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Common Type Kits
Special Type Kits

Market Segment by Applications, can be divided into
House &Office Hold
Transportation
Industrial & manufacturing facilities
Military
Outdoor
Sports
Others

Published

Read more
Global In-Vitro Diagnostics Market by Manufacturers, Regions, Type and Application, Forecast to 2023

"In vitro diagnostics are tests that can detect diseases, conditions, or infections. Some tests are used in laboratory or other health professional settings and other tests are for consumers to use at home.

Scope of the Report:
This report focuses on the In-Vitro Diagnostics in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
According to Japan’s pharmaceutical Affairs law, In-Vitro Diagnostics is defined as “medical product not administered directly to humans or animals of medicinal products used solely to diagnose disease.” Therefore, In-Vitro Diagnostics are legally classified as medicinal product and strict rules must be observed when developing, manufacturing and controlling the same. Therefore the threshold of obtaining the certification is keep new competitors from entering the market.
In-Vitro Diagnostics is a good investment choice. However, disadvantage factors and threat such as serious competition should be considered.

The worldwide market for In-Vitro Diagnostics is expected to grow at a CAGR of roughly 4.5% over the next five years, will reach 70000 million US$ in 2023, from 53900 million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers
Siemens Healthcare
Johnson and Johnson
Becton Dickinson
Abbott Laboratories
Roche Diagnostics
Beckman Coulter Inc
Thermo Scientific
Cobas
Caprion
Merck Millipore
Aptiv Solution
Danaher Corporation
Biomerieux
Bio-Rad Laboratories
Ortho Clinical Diagnostics
Sysmex Corporation
Mindray
Shanghai Kehua Bio-engineering
BioSino Bio-technology
Beijing Leadman Biochemistry
DAAN Gene

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Tissue diagnostics
Professional diagnostic
Molecular diagnostic
Diabetes Monitoring

Market Segment by Applications, can be divided into
Diabetes
Infectious Diseases
Oncology
Cardiology
HIV
Other

Published

Read more
Global Oxycodone Hydrochloride Market by Manufacturers, Regions, Type and Application, Forecast to 2023

"Oxycodone hydrochloride is a white, odorless crystalline powder derived from the opium alkaloid, thebaine. Oxycodone hydrochloride dissolves in water (1 g in 6 to 7 mL) and is considered slightly soluble in alcohol (octanol water partition coefficient is 0.7).

Scope of the Report:
This report focuses on the Oxycodone Hydrochloride in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Oxycodone hydrochloride is a white, odorless crystalline powder derived from the opium alkaloid, thebaine. Oxycodone hydrochloride dissolves in water (1 g in 6 to 7 mL) and is considered slightly soluble in alcohol (octanol water partition coefficient is 0.7). Oxycodone hydrochloride is a prescription pain reliever that may be prescribed to relieve moderate to severe pain. It can be combined with other medications, including acetaminophen and ibuprofen. In our report, oxycodone hydrochloride is calculated as API.
Oxycodone hydrochloride has been found useful as a pain killer for sever patients. The application form of oxycodone hydrochloride can be classified as four kinds: tablet, oral solution, oral capsule and intravenous fluid. Oxycodone HCl Controlled-Release tablets are a controlled-release oral formulation of oxycodone hydrochloride indicated for the management of moderate to severe pain when a continuous, around-the-clock analgesic is needed for an extended period of time. Currently, extended release tablet of oxycodone hydrochloride are produced by a majority of oxycodone hydrochloride preparation manufacturers. In 2015, the market share of tablet was 84.05%, followed by oral solution, which is also very popular among patients.

The worldwide market for Oxycodone Hydrochloride is expected to grow at a CAGR of roughly 3.1% over the next five years, will reach 7 million US$ in 2023, from 6 million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers
Mallinckrodt
Purdue Pharma
Noramco(Johnson & Johnson)
Siegfried
Cepia-Sanofi
Macfarlan Smith
Chattem Chemicals(Sun Pharma)
Temad

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Oxycodone Hydrochloride
Type II

Market Segment by Applications, can be divided into
Tablet
Oral Solution
Oral Capsule
Intravenous Fluid

Published

Read more
Global Naltrexone HCL Market by Manufacturers, Regions, Type and Application, Forecast to 2023

"Naltrexone HCL is an opioid receptor antagonist used primarily in the management of alcohol dependence and opioid dependence.

Scope of the Report:
This report focuses on the Naltrexone HCL in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Naltrexone HCL is an opioid receptor antagonist used primarily in the management of alcohol dependence and opioid dependence. As a restricted drug, Naltrexone HCL manufacturers are limited. They mainly concentrated in Europe, India, USA and China.
Global naltrexone HCL consumption areas concentrate in Europe, India and USA. Europe is the largest naltrexone HCL consumption area, which took 38.30% in 2015. India also took 21.44% and USA naltrexone HCL consumption took 18.80% of globe.

The worldwide market for Naltrexone HCL is expected to grow at a CAGR of roughly 0.9% over the next five years, will reach 21 million US$ in 2023, from 20 million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers
Taj Pharmaceuticals
Freedom Pharmaceuticals
Rusan
Sanofi
IVAX
Faran Shimi
Sun Pharma
Noramco
Haida Taicheng

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Naltrexone HCL
Type II

Market Segment by Applications, can be divided into
Opioid Independence
Alcohol Independence
Other

Published

Read more
Global Serum Market by Manufacturers, Regions, Type and Application, Forecast to 2023

"Serum is the component that is neither a blood cell (serum does not contain white or red blood cells) nor a clotting factor; it is the blood plasma not including the fibrinogens. Serum includes all proteins not used in blood clotting (coagulation) and all the electrolytes, antibodies, antigens, hormones, and any exogenous substances (e.g., drugs and microorganisms).

Scope of the Report:
This report focuses on the Serum in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market completion is intense. Thermo Fisher (Life-Tech), Sigma-Aldrich, Merck, Corning, Bovogen are the leaders of the industry, and hold the key technology and patens, with the high-end customers. They have formed global market channel of the industry. However, with the future expanding market, there will be more manufacturers in the future.
Limited by the blood source, the manufacturers in China is not many. And the product quality is unenven.

The worldwide market for Serum is expected to grow at a CAGR of roughly 4.9% over the next five years, will reach 1110 million US$ in 2023, from 840 million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers
Thermo Fisher (Life-Tech)
Sigma-Aldrich
Merck
Corning
Bovogen
Moregate Biotech
Biowest
Gemini
Bioind
Tissue Culture Biologicals
Animal Technologies
South Pacific Sera
Lanzhou Minhai
Changchun Xinuo
Wuhan Sanli

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Bovine Serum
FBS
Other

Market Segment by Applications, can be divided into
Biological Products
Research

Published

Read more
Global Methadone Hydrochloride Market by Manufacturers, Regions, Type and Application, Forecast to 2023

"Methadone Hydrochloride is a white, crystalline material that is water-soluble. It is an opioid used to treat pain or as maintenance therapy to help with detoxification in people with opioid dependence.

Scope of the Report:
This report focuses on the Methadone Hydrochloride in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
North America is the largest supplier and consumer of Methadone Hydrochloride with a production market share of 39.7% and a consumption market share of 35.6%.
The second place is Europe, following North America with the production market share of 26% and the consumption market share of 29%. Asia is another important market of Methadone Hydrochloride, enjoying 14.9% sales market share.
Market Competition is not intense, as the players are controlled by country. Eli Lilly, Sanofi, Roxane Laboratories, and Mallinckrodt are the major players in the industry. They have formed global market channel of the industry. However, with the medicine level developing, there will be more competitors in the future.

The worldwide market for Methadone Hydrochloride is expected to grow at a CAGR of roughly 4.9% over the next five years, will reach 70 million US$ in 2023, from 52 million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers
Eli Lilly
Sanofi
Roxane Laboratories
Mallinckrodt
Siegfried Ltd
MACFARLAN SMITH
Tianjin Central Pharma

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Molecular Formula
Type II

Market Segment by Applications, can be divided into
Methadone Hydrochloride Tablet
Methadone Hydrochloride Oral Solution
Other

Published

Read more
Allantoin - Global Market Outlook (2017-2026)

According to Stratistics MRC, the Global Allantoin Market is accounted for $440.0 million in 2017 and is expected to reach $887.0 million by 2026 growing at a CAGR of 8.1% from 2017 to 2026. Rising product demand for the manufacturing of different personal care products, growing demand for anti-aging product, mounting scope of applications of allantoin in the pharmaceutical products, such as eye drops and skin care creams, are some of the factors fueling the market growth. However, allantoin causes liver damage which is restricting the market growth.

Allantoin is a white powder formed by oxidation of uric acid and major excretory product of purine degradation in many vertebrates. It is present in allantoic fluid, amniotic fluid and fetal urine. It is used medicinally to promote tissue growth. It is present in botanical extracts of the comfrey plant and in the urine of various mammals. Different kinds of allantoin salts can be used in the personal care and cosmetics industries such as allantoin salts of vitamin C, allantoin ascorbate, and allantoin salts of vitamin B7. Allantoin that is used in cosmetics and personal care products is processed from urea and glyoxylic acid.

Amongst application, Oral hygiene segment accounted for significant shares in the global market. It is one of the important factors for everyday life irrespective of an individual's age. Allantoin is used in the preparation of toothpaste and mouthwash which reduces cavity and mouth ulcers. There are many social responsibility activities ongoing in developing countries and the results also showing a positive impact in sale of Oral hygiene products like mouthwashes and toothpastes. The Asia Pacific dominated the market due to rapid growth for the cosmetics industry in this region on account of rising consumer disposable income and changing lifestyle.

Some of the key players in Allantoin market include Ashland Inc., Clariant, Rita Corporation, Akema Fine Chemicals, Huanghua Suntime Chemical Industry Co. Ltd., Zhanhua Jinyuan Lide Biotechnology Co. Ltd., Luotian Guanghui Chemical Co. Ltd., Allan Chemical Corporation, EMD Performance Materials Corporation, Lubon Industry Co. Ltd., BIOSYNTH, Lisbon industry, AN PharmaTech, Sunwell chemicals and Tokyo Chemical Industry.
Applications covered:
• Oral Hygeine
• Cosmetics
• Pharmaceuticals
• Other Applications

Regions covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 9 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Published

Read more
Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Cyanocobalamin Market 2018 Forecast to 2023

"This report studies the Cyanocobalamin market, Cyanocobalamin is a man-made form of vitamin B12. Vitamin B12 is important for growth, cell reproduction, blood formation, and protein and tissue synthesis.

Scope of the Report:
This report focuses on the Cyanocobalamin in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Luitpold Pharmaceuticals
Luitpold Pharmaceuticals (Daiichi Sankyo)
Endo International
Bristol-Myers Squibb
Sanofi-Aventis
Jamieson
Teva (Actavis)
Merck
Mylan
Bayer HealthCare
Pfizer
ANGELINI
Biological E
CCEPCD
Huaxin Pharmaceutical

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Cyanocobalamin Injection
Cyanocobalamin Oral
Cyanocobalamin Spray

Market Segment by Applications, can be divided into
Hospitals
Clinics
Others

Published

Read more
Global Surgical Robotics Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

"Surgical robot can be controlled through computer program to assist surgery. A surgical robot t allows surgeons greater access to areas under operation using more precise and less invasive methods.

Scope of the Report:
This report focuses on the Surgical Robotics in global market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, types and applications.
Market Segment by Manufacturers, this report covers
Intuitive Surgical
Stryker
Mazor Robotics
Medtech S.A
THINK Surgical
Restoration Robotics
Medrobotics
TransEnterix

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Laparoscopy
Orthopedics
Other

Market Segment by Applications, can be divided into
Open Surgery
Minimal Invasive

Published

Read more
Global Phenylketonuria Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

"This report studies the Phenylketonuria (PKU) market. Phenylketonuria (PKU) is an inborn error of metabolism that results in decreased metabolism of the amino acid phenylalanine. Untreated PKU can lead to intellectual disability, seizures, behavioral problems, and mental disorder. It may also result in a musty smell and lighter skin. Babies born to mothers who have poorly treated PKU may have heart problems, a small head, and low birth weight.

Scope of the Report:
This report focuses on the Phenylketonuria in global market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, types and applications.
Market Segment by Manufacturers, this report covers
Biomarin
Mead Johnson
Abbott
Nutricia
Dr. Sch?r
Vitaflo
Cambrooke
PKU Perspectives
Firstplay Dietary

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Medications
Supplements

Market Segment by Applications, can be divided into
Household
Hospital

Published

Read more
Global Passive Temperature Controlled Packaging in Pharma Market Analysis 2012-2017 and Forecast 2018-2023

The global Passive Temperature Controlled Packaging in Pharma market will reach xxx Million USD in 2017 and CAGR xx% 2011-2017. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Passive Temperature Controlled Packaging in Pharma by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Panels and Envelopes
EPS
PUR
VIP
Other Shippers

Company Coverage (Sales Revenue, Price, Gross Margin, Main Products etc.):
Kalibox
Softbox
Intelsius

Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Primary Shipment
Secondary Shipment

Region Coverage (Regional Output, Demand & Forecast by Countries etc.):
North America
Europe
Asia-Pacific
South America
Middle East & Africa"

Published

Read more
Global Pharmacy Benefit Management (PBM) Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

Pharmacy benefit manager (PBM) is a third-party administrator (TPA) of prescription drug programs for commercial health plans, self-insured employer plans, Medicare Part D plans, the Federal Employees Health Benefits Program, and state government employee plans.

Scope of the Report:
This report focuses on the Pharmacy Benefit Management (PBM) in global market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, types and applications.
Market Segment by Manufacturers, this report covers
CVS Health (CVS)
Express Scripts
OptumRx (UnitedHealth)
Humana Pharmacy Solutions
Prime Therapeutics
Medimpact Healthcare
Magellan Health
BC/BS
Vidalink
Sea Rainbow
Cachet

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Market Segment by Applications, can be divided into
Mail-order Pharmacy Services
Non-mail Pharmacy Services

Published

Read more
Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Blood Tubing Set Market 2018 Forecast to 2023

"The blood tubing sets are used to transport blood or fluids to a patient’s vascular access device from a hemodialysis. And the reverse is also true.

This report focuses on the Blood Tubing Set in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Fresenius
Baxter
Nipro
Asahi Kasei
Bain Medical
JMS
Weigao
Tianyi Medical
NxStage Medical
Nigale
Sansin

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Adults
Children

Market Segment by Applications, can be divided into
Dialysis Center
Hospital & Clinic

Published

Read more
Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) BCG Vaccine Market 2018 Forecast to 2023

"This report studies the BCG Vaccine market. BCG Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and sometimes other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Guérin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80%of neonates and infants in countries where it is part of the national childhood immunization programme.

This report focuses on the BCG Vaccine in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Merck
Sanofi Pasteur
Japan BCG Lab
China National Biotec
Serum Institute of India
Intervax
GSBPL

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Immune BCG
Therapy BCG

Market Segment by Applications, can be divided into
Hospital
Clinic

Published

Read more
Pediatric Vaccines Market: United States Industry Analysis, Trends, Opportunity, Market Size and Segment Forecasts, 2018 - 2025

"United States pediatric vaccines market is expected to grow over US$ 15 Billion by 2025, driven by increased disease awareness, growing public acceptance, increasing government focus on immunization programs and increased government funding for the vaccines development.

“Pediatric Vaccines Market: United States Industry Analysis, Trends, Opportunity, Market Size and Segment Forecasts, 2018 - 2025”provides a unique tool for evaluating the market, highlighting opportunities, supporting strategic and tactical decision–making. This report recognizes that in this rapidly–evolving and competitive environment, up–to–date marketing information is essential to monitor performance and make critical decisions for growth and profitability. It provides information on trends and developments and focuses on United States pediatric vaccines market. The report also provides clear insight into current and future developments of the United States pediatric vaccines market. Further more, this report provides a deep and thorough evaluation of the top 10 pediatric Vaccines by disease indication. On the basis of disease indication, the top 10 pediatric Vaccines provide an in-depth analysis of doses administered number of children being vaccinated and market size. The research includes historic data from 2010 to 2017 and forecasts until 2025.

The report also explores detailed description of growth drivers and inhibitors of the United States pediatric vaccines market.

The report concludes with the profiles of major players in the United States pediatric vaccines market. The key market players are evaluated on various parameters such as company overview, pediatric vaccines portfolios and latest development & trends of the pediatric vaccines market.


The Major Companies dominating this Market for its Products, Services and Continuous Product Developments are:

• Sanofi Pasteur
• GlaxoSmithKline(GSK)
• Merck & Co.
• Pfizer Inc
• Grifols

Major Pediatric Vaccines (Disease Indication) Covered Under This Report are:

• Diphtheria, Tetanus & Pertussis (DTap)
• Hepatitis A
• Varicella/Chicken Pox
• Pneumococcal
• Haemophilus Influenzae Type B (HIB)
• Polio
• Rotavirus
• Hepatitis B
• Influenza Pediatric
• Measles, Mumps & Rubella (MMR)

The Latest Industry Data Included in this Report:

• United States Pediatric Vaccines Market Size & Analysis ,2010 – 2025
• United States Pediatric Vaccines Market Share and Y–o–Y Growth (%),2010 - 2025
• United States Pediatric Vaccines Market by Disease Indication ,2010 – 2025
• 10 Pediatric Vaccines Doses Administered (Volume),2010 - 2025
• Number of Children Being Vaccinated (Volume)2010 - 2025
• 10 Pediatric Vaccines Market Size and Forecast(Value),2010 - 2025
• Key Market Drivers and Inhibitors of the United States Pediatric Vaccines Market
• A Comprehensive List of Key Market Players Along with the Analysis of their Current Product Portfolios and Latest Recent Development and Trends

The following key questions have been addressed in the report:

• What is the size of the United States pediatric vaccines market during 2010 -2025?
• How will each segment of the United States pediatric vaccines market grow during the forecast period and what will be the revenue generated by each of the segments by the end of 2025?
• Which major pediatric vaccines provides highest market share?
• How much number of children being vaccinated during 2010-2025?
• How are the overall market and segments types growing?
• What are the major market drivers and inhibitors in the United States pediatric vaccines market?
• Who are the key players in the United States pediatric vaccines market and what are their contributions?
"

Published

Read more
Global Coronary Atherectomy Devices Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

"Atherectomy is defined as minimally invasive surgery for removal of plaque blockages from coronary.

Scope of the Report:
This report focuses on the Coronary Atherectomy Devices in global market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, types and applications.
Market Segment by Manufacturers, this report covers
Boston Scientific
Philips
Cardiovascular Systems

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Laser Atherectomy
Orbital Atherectomy
Rotational Atherectomy
Others

Market Segment by Applications, can be divided into
Hospitals
Clinics
Ambulatory Surgery Centers

Published

Read more
Global Allergy Immunotherapy Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

"Allergen immunotherapy, also known as desensitization or hypo-sensitization, is a medical treatment for some types of allergies. It is useful for environmental allergies, allergies to insect bites, and asthma. Its benefit for food allergies is unclear and thus not recommended. Immunotherapy involves exposing people to larger and larger amounts of allergen in an attempt to change the immune system's response.

Scope of the Report:
This report focuses on the Allergy Immunotherapy in global market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, types and applications.
Market Segment by Manufacturers, this report covers
ALK-Abello
Stallergenes Greer
Merck
Allergy Therapeutics
HAL
WOLW Pharma
Holister Stier
Leti

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Subcutaneous Immunotherapy
Sublingual Immunotherapy

Market Segment by Applications, can be divided into
Allergic Rhinitis
Allergic Asthma
Other

Published

Read more
Global Advanced Wound Care Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

"This report studies the Advanced Wound Care market, Advanced wound care products are designed to treat more complex wounds and—in order to be covered under insurance—usually require a doctor’s order. This includes hydrogels, hydrocolloids, alginates, and film and foam dressings. Advanced wound care treatments revolve around the principle of moisture therapy, which provides moisture to the wound site to encourage natural cell repair while giving the wound room to breathe. Products utilized in moist wound care generally fit better around different wound shapes and sizes and are more resistant to environmental inhibitors and foreign particles.

Scope of the Report:
This report focuses on the Advanced Wound Care in global market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, types and applications.
Market Segment by Manufacturers, this report covers
Acelity
Smith & Nephew
Molnlycke
ConvaTec
Coloplast
Organogenesis
Integra Lifesciences Corporation
Medline Industries
3M
Hollister Incorporated
Human Biosciences
Medtronic
Hartmann Group
B.Braun Melsungen
BSN Medical
Urgo Medical
Mimedx Group, Inc.
Nitto Denko
Winner Medical Group

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Advanced Wound Dressings
Bioactives
Devices

Market Segment by Applications, can be divided into
Acute wounds
Chronic Wounds
Surgical Wounds

Published

Read more
Global Pimozide Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

"Pimozide (sold under the brand name Orap) is an antipsychotic drug of the diphenylbutylpiperidine class. It was discovered at Janssen Pharmaceutica in 1963. It has a high potency compared to chlorpromazine (ratio 50-70:1). On a weight basis it is even more potent than haloperidol. It also has special neurologic indications for Tourette syndrome and resistant tics. The side effects include akathisia, tardive dyskinesia, and, more rarely, neuroleptic malignant syndrome and prolongation of the QT interval.

Scope of the Report:
This report focuses on the Pimozide in global market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, types and applications.
Market Segment by Manufacturers, this report covers
Teva
Par Pharmaceutical
Johnson & Johnson
Eumedica
Pharmascience
Domina Pharmaceuticals
Aa Pharma

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
1Mg
2Mg
4Mg

Market Segment by Applications, can be divided into
Hospitals
Drugstores
Others

Published

Read more
Global Orthopedic Braces & Support Casting & Splints Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

"Orthopedic braces are medical devices designed to address musculoskeletal issues; they are used to properly align, correct the position, support, stabilize, and protect certain parts of the body (particularly the muscles, joints, and bones) as they heal from injury or trauma. These medical devices are often prescribed for the patient to wear during the process of recovery and rehabilitation.

Scope of the Report:
This report focuses on the Orthopedic Braces & Support Casting & Splints in global market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, types and applications.
Market Segment by Manufacturers, this report covers
DJO Global
Ottobock
Ossur
3M Company
Bauerfeind
DeRoyal
Medi GmbH & Co.
Zimmer
Lohmann & Rauscher
Breg
THUASNE
ORTEC
BSN Medical
Tynor Orthotics
DUK-IN
Prime Medical
Adhenor
Aspen
Rcai
Truelife
Huici Medical
Dynamic Techno Medicals

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Braces & Support
Casting Supplies
Splinting Supplies

Market Segment by Applications, can be divided into
Hospitals
Retail Pharmacies
Online Sales

Published

Read more
Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Infrared Heaters Market 2018 Forecast to 2023

"An infrared heater is a body with a higher temperature which transfers energy to a body with a lower temperature through electromagnetic radiation. Depending on the temperature of the emitting body, the wavelength of the peak of the infrared radiation ranges from 780 nm to 1 mm. No contact or medium between the two bodies is needed for the energy transfer. Infrared heaters can be operated in vacuum or atmosphere.

Scope of the Report:
This report focuses on the Infrared Heaters in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Jarden Consumer Solutions
Twin-Star
Edenpure
Schwank
Tansun
Honeywell
IR Energy
Dr Infrared Heater
Lifesmart
Midea
Infralia
Airmate
Solamagic
FRICO
Thermablaster
Singfun
Gree

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Near Infrared Heaters
Medium Infrared Heaters
Far Infrared Heaters

Market Segment by Applications, can be divided into
Outdoor
Indoor
 

Published

Read more
Global Anti-decubitus Cushions Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

This report focuses on the Anti-decubitus Cushions in global market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, types and applications.
Market Segment by Manufacturers, this report covers
Varilite
Permobil
Ottobock
Invacare
Sunrise Medical
Winncare Group
Action Products
Yuwell
Drive DeVilbiss
Trulife
Supracor
Young Won Medical
Star Cushion
SPM
Aquila Corporation

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Air Cushions
Gel Cushions
Foam Cushions
Others

Market Segment by Applications, can be divided into
Hospitals
Recuperation Institutions
Home

Published

Read more
Global Patient Lateral Transfer Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

"Performing lateral patient transfers is a common task in the daily tasks of healthcare workers. Although somewhat routine and performed in high quantities, transferring patients from one surface to another can become complicated and cause potential injuries to the staff and the patient.

Scope of the Report:
This report focuses on the Patient Lateral Transfer in global market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, types and applications.
Market Segment by Manufacturers, this report covers
Stryker
Arjo
Handicare
Hill-Rom
Joerns Healthcare
Medline
Sizewise
Airpal
Air-Matt
Cantel Medical
EZ Way
Hovertech
PPS
Wy’East Medical

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Air Assisted Transfer Device
Slide Sheets

Market Segment by Applications, can be divided into
Hospitals
Ambulatory Surgical Centers
Others

Published

Read more
Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Ursodeoxycholic Acid Market 2018 Forecast to 2023

"""Ursodeoxycholic Acid is also known as ursodiol (USAN). Ursodeoxycholic acid (3α, 7β-2-hydroxy-5β-bile acid, UDCA) was first found in the bile of a black bear.

Ursodeoxycholic Acid is an important clinical drug in the treatment of gallstones, cholecystitis, PBC, and PSC and has broad market prospects. In previous work, ursodeoxycholic acid was prepared by traditional organic synthesis.""

Scope of the Report:
This report focuses on the Ursodeoxycholic Acid in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
ICE
Mitsubishi Tanabe Pharma
Daewoong Chemical
PharmaZell GmbH
Zhangshanbelling
Dipharma Francis
Grindeks
Erregierre
Abil Chempharma
Biotavia Labs
Suzhou Tianlu
Arcelor Chemicals

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Synthetic UDCA
Extraction UDCA

Market Segment by Applications, can be divided into
Pharmacy
Health Products

Published

Read more
Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Foam Dressing Market 2018 Forecast to 2023

"A Foam Dressing, consists of sterile polyurethane foam, hydrocolloid adhesive (polystyrene, sodium carboxymethyl cellulose, etc.), which is an opaque polyurethane dressing that is permeable to vapors but partially occlusive to liquids. It is typically used to cover wounds over bony ridges or near inflamed skin, especially in burns, open wounds, pressure ulcers,venous ulcers, diabetic, etc.

Scope of the Report:
This report focuses on the Foam Dressing in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Smith & Nephew
M?lnlycke Health Care
Coloplast Corp
3M
ConvaTec
Acelity
Medline Industries, Inc
Cardinal Health
B.Braun
Medtronic
Hollister Incorporated
Paul Hartmann
Top-medical
Lohmann & Rauscher
Winner Medical Group
Derma Sciences

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Adhesive Foam Dressing
Non-Adhesive Foam Dressing

Market Segment by Applications, can be divided into
Acute Wounds
Postoperative Wounds
Chronic Wounds

Published

Read more
Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Duchenne Muscular Dystrophy Market 2018 Forecast to 2023

"Duchenne muscular dystrophy is an x-linked genetic disorder that affects mostly boys. In Duchenne, boys begin to show signs of muscle weakness as early as two to five years of age. The disease gradually weakens the skeletal or voluntary muscles in the arms, legs and trunk. Due to progressive muscle weakness, Duchenne patients are often wheelchair bound between the ages of seven and 13 years old. At a later stage, the boys' respiratory and cardiac muscles are also affected and for most boys, respiratory and cardiac failure are major causes of death, often prevalent by the age of 20.

Scope of the Report:
This report focuses on the Duchenne Muscular Dystrophy in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
PTC Therapeutics
Sarepta Therapeutics
Bristol-Myers Squibb
ITALFARMACO
BioMarin
Daiichi Sankyo
Solid Biosciences
Summit Therapeutics
FibroGen
NS Pharma
Pfizer
ReveraGen BioPharma
Wave Life
Genethon
Santhera Pharmaceuticals

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Deflazacort
Prednisone
Others

Market Segment by Applications, can be divided into
Male
Female

Published

Read more
Global Ubiquinone Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

"This report studies the Ubiquinone market, Coenzyme Q10, also known as ubiquinone, ubidecarenone, coenzyme Q, and abbreviated at times to CoQ10, is a naturally-occurring compound located in every cell in the body. Coenzyme Q10, or merely CoQ10, plays a key role in producing energy in the mitochondria, the part of a cell responsible for the production of energy in the form of ATP. Coenzyme Q10, in some cases referred to merely as CoQ10, is synthesized inside our bodies, it is also known to be found in meats, particularly in the heart, such as pork, chicken and beef, and many oils.

Scope of the Report:
This report focuses on the Ubiquinone in global market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, types and applications.
Market Segment by Manufacturers, this report covers
Kingdomway
Kaneka
ZMC
Space Biology
NHU
Pharma Essentia
Yuxi Jiankun
Haotian

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Chemical Synthesis
Microbial Fermentation
Others

Market Segment by Applications, can be divided into
Food
Medicine
Cosmetics
Others
 

Published

Read more
Global Indirect Restorative Materials of Dental Consumables Market by Manufacturers, Countries, Type and Application, Forecast to 2023

"Indirect tooth restoration involves customized tooth replacements in the form of crowns, onlays, or inlays. A crown covers the entire chewing surface of a tooth, an inlay lies within the cusps of the tooth, and an onlay covers and one or more cusp tip, including part of the chewing surface. An indirect tooth restoration will require more than one office visit because the inlay or onlay must be fabricated in a lab. Crowns, inlays and onlays can be made from a variety of materials. Gold is still used for some inlays, but for someone concerned about white teeth, porcelain and tooth-colored composite resins are other options.

Scope of the Report:
This report focuses on the Indirect Restorative Materials of Dental Consumables in global market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, types and applications.
Market Segment by Manufacturers, this report covers
3M ESPE
Dentsply Sirona
Danaher
GC Corporation
Ivoclar Vivadent
Shofu
Mitsui Chemicals (Heraeus Kulzer)
VOCO GmbH
Ultradent
Coltene
DMG

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
All-Ceramic
Porcelain Fused to Metal
Cast-Gold Alloys

Market Segment by Applications, can be divided into
Hospital
Dental

Published

Read more
Global Human Coagulation Factor VIII Market by Manufacturers, Countries, Type and Application, Forecast to 2023

"Human Coagulation Factor VIII is an essential blood-clotting protein, also known as anti-hemophilic factor (AHF). In humans, factor VIII is encoded by the F8 gene, defects in this gene results in hemophilia A.

Scope of the Report:
This report focuses on the Human Coagulation Factor VIII in global market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, types and applications.
Market Segment by Manufacturers, this report covers
Shire (Baxter)
Bayer
CSL
Pfizer
Grifols
Biogen
Octapharma
NovoNordisk
Greencross
Kedrion
BPL
Hualan Bio
RAAS

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Recombinant Factor VIII
Plasma-derived Factor VIII

Market Segment by Applications, can be divided into
Hemophilia A
Spontanous / Trauma
Spontanous / Trauma
Other

Published

Read more
Global Epinephrine Market by Manufacturers, Countries, Type and Application, Forecast to 2023

Scope of the Report:
This report focuses on the Epinephrine in global market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, types and applications.
Market Segment by Manufacturers, this report covers
Mylan Inc
Sanofi SA
Impax
ALK Abello
Lincoln Medical Ltd
AMPHASTAR

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Epinephrine Auto-injector
Epinephrine Prefilled Syringe
Others

Market Segment by Applications, can be divided into
Anaphylaxis
Others

Published

Read more
Global All Vaccine Market by Manufacturers, Countries, Type and Application, Forecast to 2023

Scope of the Report:
This report focuses on the All Vaccine in global market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, types and applications.
Market Segment by Manufacturers, this report covers
CNBG
ChengDa Bio
Changsheng Life
Zhifei
SINOVAC BIOTECH
NuoCheng Bio
Hualan Bio
Kangtai
SANOFI PASTEUR S.A.
Novartis
GSK

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Varicella
Influenza
Polio
Hepatitis A
Rabies
BCG
Hepatitis B
Pertussis, Diphtheria, tetanus
Pneumococcal
Other

Market Segment by Applications, can be divided into
For Adult
For Child

Published

Read more
Global Botox Market by Manufacturers, Countries, Type and Application, Forecast to 2023

"Botox is a neurotoxic protein produced by the bacterium Clostridium botulinum and related species in the reproduction process. Botox is a polypeptide which molecular weight is 150kD and is also one of the most poisonous natural proteins. It is so easy to be produced, purified and refined due to its stable property that Botox is used widely in Experimental Research and Clinical Application at the early stage.

Scope of the Report:
This report focuses on the Botox in global market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, types and applications.
Market Segment by Manufacturers, this report covers
Allergan
Ipsen
Merz Pharmaceuticals
Medytox
US World Meds
LIBP

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
50U
100U
Others

Market Segment by Applications, can be divided into
Medical
Cosmetic

Published

Read more
Global Active Pharmaceutical Ingredients Market by Manufacturers, Countries, Type and Application, Forecast to 2023

"This report studies the Active Pharmaceutical Ingredients market. An active ingredient (AI) is the ingredient in a pharmaceutical drug that is biologically active. The similar terms active pharmaceutical ingredient (API) and bulk active are also used in medicine, and the term active substance may be used for natural products. Some medication products may contain more than one active ingredient. The traditional word for the API is pharmacon or pharmakon which originally denoted a magical substance or drug.

Scope of the Report:
This report focuses on the Active Pharmaceutical Ingredients in global market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, types and applications.
Market Segment by Manufacturers, this report covers
Teva
Mylan
DSM
Aurobindo Pharma
Aspen
Novartis
BASF
Pfizer
Huahai Pharmaceutical
Hisun Pharmaceutical
Sun Pharmaceutical Industries
Zhejiang Medicine
Dr. Reddy’s Laboratories
Zhejiang NHU
Bayer
NCPC
AbbVie
Shandong Xinhua Pharmaceutical
Northeast Pharm
Harbin Pharmaceutical
LKPC

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Synthetic APIs
Biotech APIs

Market Segment by Applications, can be divided into
CNS
Cardiovascular
Genitourinary/Hormonal Drugs
Respiratory
Rheumatology
Diabetes
Oncology
Others

Published

Read more
Global Cytokines Market by Manufacturers, Countries, Type and Application, Forecast to 2023

"""Cytokines are a large group of small signaling molecules that function extensively in cellular communication. Cytokines are most often associated with various immune modulating molecules that include interleukins, chemokines, and interferons, but can also include other molecules as well. Their use in disease diagnosis and treatment has proven very beneficial over the past number of years as their use as biomarkers has been adopted as a means to understanding disease and therapies. They have expanded into more disease relevant, specialized panels for a more accurate assessment of various diseases that include cardiovascular disease, asthma, inflammation, cancer, diabetes, and rheumatoid arthritis.
""
Scope of the Report:
This report focuses on the Cytokines in global market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, types and applications.
Market Segment by Manufacturers, this report covers
AbbVie
Johnson & Johnson
GlaxoSmithKline
Novartis
Roche
Pfizer
Sanofi
Bayer HealthCare Pharmaceuticals
Thermo Fisher Scientific
Biocon
Biotechne

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
TNF
IL
IFN
EGF
Others

Market Segment by Applications, can be divided into
Cancer and Malignancy
Asthma / Airway Inflammation
Arthritis
Others

Published

Read more
Global Monoclonal Mouse Antibody Market by Manufacturers, Countries, Type and Application, Forecast to 2023

"Monoclonal Antibodies (IgMs) are antibodies that are made by identical immune cells, cloned from a single parent cell. They are therefore of constant structure and bind to the same foreign markers (called “antigens”). The technology behind the generation of monoclonal antibodies was discovered in 1972 by César Milstein and Georges Kohler – scientists at the Roche-funded Basel Institute for Immunology – who were later to win the Nobel Prize. Monoclonal antibodies revolutionized biological research and built the basis for the use of therapeutic antibodies in medicine and for the entire biotechnology industry.

Scope of the Report:
This report focuses on the Monoclonal Mouse Antibody in global market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, types and applications.
Market Segment by Manufacturers, this report covers
Roche
Johnson & Johnson
Merck
Novartis
AbbVie
Amgen
Pfizer
Bayer
Lilly
Bristol-Myers Squibb
GlaxoSmithKline
Biogen
AstraZeneca
Sanofi
Alexion Pharmaceuticals
Seattle Genetics

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
IgM
IgG
IgA
Other

Market Segment by Applications, can be divided into
Therapeutic
Research
Diagnostic

There are 15 Chapters to deeply display the global Monoclonal Mouse Antibody market.

Chapter 1, to describe Monoclonal Mouse Antibody Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Monoclonal Mouse Antibody, with sales, revenue, and price of Monoclonal Mouse Antibody, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Monoclonal Mouse Antibody, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the key regions, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Monoclonal Mouse Antibody market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Monoclonal Mouse Antibody sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source"

Published

Read more
Global Gene Synthesis Market by Manufacturers, Countries, Type and Application, Forecast to 2023

"Gene synthesis refers to chemically synthesizing a strand of DNA base-by-base. Unlike DNA replication that occurs in cells or by Polymerase Chain Reaction (PCR), gene synthesis does not require a template strand. Rather, gene synthesis involves the step-wise addition of nucleotides to a single-stranded molecule, which then serves as a template for creation of a complementary strand. Gene synthesis is the fundamental technology upon which the field of synthetic biology has been built.

Scope of the Report:
This report focuses on the Gene Synthesis in global market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, types and applications.
Market Segment by Manufacturers, this report covers
Genescript
GeneArt (Thermofischer)
IDT
DNA 2.0 (ATUM)
OriGene
BBI
Genewiz
Eurofins Genomics
Gene Oracle
SBS Genetech
Bio Basic

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Market Segment by Applications, can be divided into
Commercial
Academic Research

There are 15 Chapters to deeply display the global Gene Synthesis market.

Chapter 1, to describe Gene Synthesis Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Gene Synthesis, with sales, revenue, and price of Gene Synthesis, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Gene Synthesis, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the key regions, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Gene Synthesis market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Gene Synthesis sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source"

Published

Read more
United States Pediatric Vaccine Market 2017 – Demand, Insights, Analysis, Opportunities Segmentation and Forecast to 2024

"United States Pediatric Vaccine market is likely to reach nearly US$ 10 Billion by 2024.

Growth in US pediatric vaccine market can be attributed to factors such as increased disease awareness, growing public acceptance, increasing government focus on immunization programs and increased government funding for the vaccine development.

The research report titled “United States Pediatric Vaccine Market 2017 – Demand, Insights, Analysis, Opportunities Segmentation and Forecast to 2024” examines the market dynamics, competitive landscape and discusses major trends. The study describes an in–depth analysis of the United States pediatric vaccine market.

The report contains a granular analysis of the market segmentation, reveal facts on the market size, volume and revenues and provides forecasts through 2024. The report also provides a deep and thorough evaluation of the top 10 pediatric vaccines by disease indication. On the basis of disease indication, the top 10 pediatric vaccines provide an in-depth analysis of doses administered, number of children being vaccinated and market size. The report also explores detailed description of growth drivers and inhibitors of the United States pediatric vaccine market.

The report concludes with the profiles of major players in the United States pediatric vaccine market. The key market players are evaluated on various parameters such as company overview, pediatric vaccine portfolios and latest development & trends of the pediatric vaccine market.


Major Pediatric Vaccines (Disease Indication) Covered Under This Report Are:

Diphtheria, Tetanus & Pertussis (DTap)
Hepatitis A
Varicella/Chicken Pox
Pneumococcal
Haemophilus Influenzae Type B (HIB)
Polio
Rotavirus
Hepatitis B
Influenza Pediatric
Measles, Mumps & Rubella (MMR)


Key Companies Covered in the Report are as follows:

Sanofi Pasteur
GlaxoSmithKline(GSK)
Merck & Co.
Pfizer Inc
Grifols

Key Deliverables in the Study

Market Definition for the specified topic along with identification of key drivers and inhibitors for the market
It provides a growth map over time to understand the industry growth rate
It provides a seven-year forecast assessed based on how the market is predicted to grow
It helps in understanding the key product segments and their future
It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
A comprehensive list of key market players along with the analysis of their current pediatric vaccines portfolios and latest development and trends.
"

Published

Read more
Flu Vaccine Market Outlook 2024: United States Opportunity and Demand Analysis, Market Forecast 2017-2024

"United States flu vaccine market is expected to reach nearly US$ 3 Billion by 2024. Growth in US flu vaccine market can be attributed to factors such as increased disease awareness, expanded recommendations by governmental and advisory bodies to be vaccinated against flu vaccine and introduction of quadrivalent flu vaccine.

Long–term Growth Projection and Development:

• Sanofi to Acquire Protein Sciences Corporation
• It is likely that more than 185 Million persons being vaccinated with flu vaccines in 2024.
• Nearly 160 Million doses of flu vaccines have shipped to US for the 2017-2018 flu season
• It is projected that GSK flu vaccine sales value will reach around US$ 1.5 Billion by 2024
• BiondVax reports positive phase 2b clinical trial results for its universal flu vaccine

“Flu Vaccine Market Outlook 2024: United States Opportunity and Demand Analysis, Market Forecast 2017-2024” provides a deep and thorough evaluation of the United States flu vaccine market. The report provides an in–depth analysis of the flu vaccination pattern in both Children and Adults in the United States. It also provides essential insights into flu vaccine production, price, consumption, supply, distribution, demand and specification. It also covers reimbursement pattern and offers a clear view of the regulatory landscape. Additionally, the report includes assessment of clinical trials and promising flu vaccines in the clinical development. Key trends in terms of M&A, collaborations and licensing agreements are analyzed with details.

The report concludes with the profiles of major players in the US flu vaccine market such as Sanofi Pasteur, GSK and Seqirus. The major market players are evaluated on various parameters such as company overview, product outlook, latest development & trends and sales analysis of flu vaccine market from 2011 to 2022. The report also entails major drivers and inhibitors in the US flu vaccine market.

Key Topics Covered in the Report

• Market Overview: United States Flu Vaccine Market (2010 - 2024)
• United States Number of Persons Vaccinated with Flu Vaccine (2010 - 2024)
• United States Flu Vaccine Production, Price, Consumption, Supply, Distribution, Demand and Specification
• Reimbursement & Regulatory System in the US Flu Vaccine Market
• Mergers, Acquisitions, Key Agreements & Collaborations
• Promising Flu Vaccine in Clinical Development
• Flu Vaccine Clinical Trial Insights by Phase, Company & Country
• Key Drivers and Inhibitors of the US Flu Vaccine Market
• Key Companies Analysis

Major Flu Vaccines Covered Under This Report Are:


• Fluzone High–Dose
• Fluzone Quadrivalent
• Intradermal (ID) Trivalent
• Vaxigrip
• Fluarix Quadrivalent
• Flulaval Quadrivalent
• Flucelvax Quadrivalent
• Afluria Quadrivalent
• Agrippal
• Fluad
• Fluvirin
• Fluvax

Key Companies Covered in This Report:

• Seqirus
• Sanofi Pasteur
• GlaxoSmithKline(GSK)
"

Published

Read more
Epilepsy Drugs Market: Global Demand, Growth Potential & Opportunity Outlook 2021

"Epilepsy Drugs Market is likely to reach nearly USD 5.5 Billion by the year end of 2021.

Market growth can be attributed to factors such as rising incidence of neurological disorders, growing disease awareness, introduction of novel antiepileptic drugs (AEDs), strong government support and initiatives. Moreover, increasing R&D investment and launch of extended-release formulations are further expected to fuel the market growth. However, high cost of patented drugs, concerns over decreasing healthcare costs as part of government austerity measures, particularly in Europe and low accessibility to antiepileptic drugs in low and middle income countries, are likely to restrict the market growth.

Vimpat is the undisputed leading drug of Global Epilepsy Drugs Market. It has a market share of nearly 22% in 2016 and is expected that Vimpat will gain its momentum till the forecasting period. Keppra was the second highest market share taker with more than 19% share in 2016 but the prospect of this drug will change due to the patent expiration in 2018 and its share decline to XX% by 2021. It is expected that Lamictal will be second leading drug with nearly XX% share by 2021. Onfi hold the third highest share of the Epilepsy Drugs market, being followed by Depakine by the year end of 2021.

The research report titled “Epilepsy Drugs Market: Global Demand, Growth Potential & Opportunity Outlook 2021” examines the market, competitive landscape and trends of the Global Epilepsy Drug Market. This report analyzes market data and provides a better understanding of Epilepsy Drugs sales value and demand in the Global Market. Market outlook in value terms for the forecasted period for Epilepsy Drugs Market has been detailed in the report. Key trends in terms of collaborations, partnerships and licensing agreements are analysed with details. The report also explores detailed description of growth drivers and inhibitors of the Global Epilpesy Drugs Market.

The report concludes with the profiles of major players in the Epilepsy Drugs Market such as UCB, EISAI, Pfizer, Sanofi and Lundbeck. The major market players are evaluated on various parameters such as company overview and latest development and trends in the Epilepsy Drugs Market


Key Topics Covered in the Report

• Worldwide Epilepsy Drugs Market Analysis (2013 – 2021)
• Worldwide Epilepsy Drugs Market Share (2013 – 2021)
• Worldwide Epilepsy Drugs Brand Market Performance (2013 – 2021)
• Epilepsy Drugs Market – Major Deal Types
• Key Companies Analysis
• Key Drivers and Inhibitors of the Epilepsy Drugs Market

Key Epilepsy Drugs Covered in the Report are as follows:

1. Vimpat(Lacosamide)
2. Keppra(Levetiracetam)
3. Briviact(Brivaracetam)
4. Lamictal(Lamotrigine)
5. Neurontin (Gabapentin)
6. Depakine (Sodium Valproate)
7. Sabril (Vigabatrin)
8. Onfi(Clobazam)
9. Fycompa(Perampanel)
10. Inovelon/Banzel(Rufinamide)
11. Zonegran (Zonisamide)
12. Zebinix (Eslicarbazepine Acetate)

Key Companies Covered in the Report are as follows:

1. UCB
2. EISAI
3. Pfizer
4. Sanofi
5. Lundbeck
"

Published

Read more
Influenza Vaccines Market in Top 5 European Countries to 2022 - Market Size, Development and Forecasts

"Influenza Vaccine Market is expected to reach more than US$ 1 Billion across the 5 major markets (5MM) of the France, Germany, Italy, Spain and United Kingdom by the year end of 2022.

Market growth can be attributed to factors such as increased disease awareness, expanded recommendations by governmental and advisory bodies to be vaccinated against Influenza, introduction of quadrivalent influenza vaccines, increase in the size of the elderly population in most countries.

United Kingdom influenza vaccine market is the most attractive of those covered in the report. The United Kingdom market for influenza vaccine is expected to grow at a CAGR of XX% and is expected to reach at US$ XXX Million by the end of the forecasted period. Germany will be the second–largest market for influenza vaccine which is expected to grow at a CAGR of XX% by 2022. France is expected to be third largest influenza vaccine market being followed by Italy by the end of the forecasted period.

Further, prudent analysis has been done on the competitor’s part, where three major players grab major share of the influenza vaccine market by revenue. Sanofi Pasteur, GlaxoSmithKline(GSK), Seqirus, AstraZeneca and Protein Sciences Corporation are the key influencers with their products in the influenza vaccine market. Other emerging players such as Novavax, Daiichi–Sankyo, Mitsubishi Tanabe Pharma, BiondVax Pharmaceuticals Ltd, and VaxInnate are making novel technology based influenza vaccine which is likely to affect the market share during the forecast period.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry–validated market data. It also contains projection using a suitable set of assumptions and methodologies. It provides essential insights into influenza vaccine sales forecast for the top five countries, comprising the UK, France, Italy, Spain and Germany until 2022. It also covers vaccination patterns and geographic distribution and offers a clear view of the regulatory landscape. Additionally, the report includes assessment of clinical trials, pipeline and promising vaccines in influenza vaccine market. Key trends in terms of M&A, collaborations and licensing agreements are analyzed with details. The report concludes with the profiles of major players

in the influenza vaccine market, such as Sanofi Pasteur, GSK, Sequirus, AstraZenecca and Protein Sciences Corporation. The major market players are evaluated on various parameters such as company overview, product outlook and sales analysis of influenza vaccine market from 2011 to 2022. The report also entails major drivers and barriers of influenza vaccine market.

Five Major European Markets(5MM) covered in the report are as follows:

1. United Kingdom
2. France
3. Italy
4. Spain
5. Germany

Major and Promising Vaccines covered in the report are as follows:

1. Fluzone High–Dose
2. Fluzone Quadrivalent
3. Intradermal (ID) Trivalent
4. Vaxigrip
5. Fluarix Quadrivalent
6. Flulaval Quadrivalent
7. Fluenz Tetra
8. FluMist Quadrivalent
9. Flublok
10. VN–100
11. M–001
12. VAX–2012Q
13. TAK – 850
14. Flucelvax Quadrivalent
15. Afluria Quadrivalent
16. Agrippal
17. Fluad
18. Fluvirin
19. Fluvax

Key Companies Covered in the Report are as follows:

1. Sanofi Pasteur
2. GlaxoSmithKline(GSK)
3. Seqirus
4. AstraZenecca
5. Protein Sciences Corporation
6. Novavax
7. Daiichi–Sankyo
8. Mitsubishi Tanabe Pharma
9. BiondVax Pharmaceuticals Ltd
10. VaxInnate

"

Published

Read more
Zika Virus Vaccines by Company Profile, Deals Type, Funding, Clinical Trials Insight, Regulatory Landscape & Recent Development

"It is predicted that Zika virus vaccines shot will available to the public by 2018.

Zika virus is an emerging viral disease that is transmitted through the bite of an infected mosquito, primarily Aedes aegypti, the same vector that transmits chikungunya, dengue and yellow fever. Zika has a similar epidemiology, clinical presentation and transmission cycle in urban environments as chikungunya and dengue, although it generally causes milder illness.

The highest risk is to pregnant women due to the connection the virus has with serious birth defects. Pregnant women who contract the virus have a high possibility of giving birth to a baby with microcephaly, a neurodevelopment disorder, where a baby is born with an unusually small head due to abnormal brain development in the womb or after birth. Complications of this disorder include seizures and developmental issues.

Due to the serious nature of global risk, the WHO has declared the microcephaly cases associated with the Zika virus a Public Health Emergency of International Concern (PHEIC). With no vaccines or cure the virus and its risks are expected to continue to spread. The WHO is predicting up to 4 Million Zika cases in the Americas by 2016 and the World Bank is projecting the short-term economic impact for 2016, in Latin America and the Caribbean to be about US$3.5 Billion.

With fears of Zika virus reaching new heights, Zika virus vaccines are gaining popularity. Many Government agencies and research institutes support pharmaceutical companies for the development & manufacturing of Zika virus vaccines. It is predicted that Zika virus vaccines shot will available to the public by 2018.

The research report presents a comprehensive study of the Zika virus vaccines with details. It provides essential insights of introduction of Zika virus, current situation and areas with Zika virus and funding in Zika virus vaccines research. Additionally, the report includes assessment of clinical trials and regulatory landscape of Zika virus vaccines development. Key trends in terms of partnerships, collaborations and licensing agreements are analyzed with details.

The report concludes with the profiles of major players in the Zika virus vaccines development such as Sanofi Pasteur, ImmunoVaccines Inc, Inovio Pharmaceuticals, Inc, Valneva, Bharat Biotech International Pvt. Ltd., NewLink Genetics. The major players are evaluated on various parameters such as company overview, product outlook and Zika virus vaccines latest development and trends.

This 87 Page report has been analyzed from 7 viewpoints:

1. Zika Virus – Introduction, Signs and Symptoms, Transmission, Diagnosis, Treatment & Prevention
2. Current Situation & Areas with Zika Virus
3. Competitive Landscape of The Zika Virus Vaccines Companies
4. Funding in Zika Virus Vaccines Research
5. Zika Virus Vaccines – Clinical Trials Insight by Phase & Trial Status
6. Zika Virus Vaccines – Regulatory Landscape
7. Key Companies Analysis
"

Published

Read more
United States Influenza Vaccine Market, Vaccination Analysis, Distribution, Production, Pipeline Insights, Clinical Trials, Deals Type, Regulatory, Price Trends, Competitive Strategies and Forecast,2016 to 2022

"United States Influenza Vaccine Market is expected to reach more than US$ 2.5 Billion by the year end of 2022.

Market growth can be attributed to factors such as increased disease awareness, expanded recommendations by governmental and advisory bodies to be vaccinated against influenza vaccine and introduction of quadrivalent influenza vaccine.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry–validated market data. It provides essential insights into United States influenza vaccine market and forecast. It covers vaccination pattern, doses distribution, production and offers a clear view of the regulatory landscape. Additionally, the report includes insight of clinical trials, pipeline and promising vaccines in United States influenza vaccine market. Key trends in terms of M&A, collaborations and licensing agreements are analyzed with details.

The report concludes with the profiles of major players in the influenza vaccine market such as Sanofi Pasteur, GSK, Seqirus, AstraZenecca and Protein Sciences Corporation. The major market players are evaluated on various parameters such as company overview, product outlook and sales analysis of influenza vaccine market from 2011 to 2022. Other emerging players such as Novavax, Daiichi–Sankyo, Mitsubishi Tanabe Pharma, BiondVax Pharmaceuticals Ltd, and VaxInnate are making novel technology based influenza vaccine which is likely to affect the market share during the forecast period. The report also entails major drivers and barriers of influenza vaccine market.

Major and Promising Vaccine covered in the report are as follows:

1. Fluzone High–Dose
2. Fluzone Quadrivalent
3. Intradermal (ID) Trivalent
4. Vaxigrip
5. Fluarix Quadrivalent
6. Flulaval Quadrivalent
7. Fluenz Tetra
8. FluMist Quadrivalent
9. Flublok
10. VN–100
11. M–001
12. VAX–2012Q
13. TAK – 850
14. Flucelvax Quadrivalent
15. Afluria Quadrivalent
16. Agrippal
17. Fluad
18. Fluvirin
19. Fluvax

Key Companies Covered in the Report are as follows

1. Sanofi Pasteur
2. GlaxoSmithKline(GSK)
3. Seqirus
4. AstraZenecca
5. Protein Sciences Corporation
6. Novavax
7. Daiichi–Sankyo
8. Mitsubishi Tanabe Pharma
9. BiondVax Pharmaceuticals Ltd
10. VaxInnate
"

Published

Read more
Seasonal Influenza Vaccine Market Size, Country Outlook, Vaccination Analysis, Pipeline Insights, Clinical Trials Statement, Deals Type, Regulatory, Price Trends, Competitive Strategies and Forecast,2016 to 2022

"Seasonal Influenza Vaccine Market is expected to reach more than US$ 4 Billion across the seven major markets (7MM) of the United States, France, Germany, Italy, Spain, United Kingdom and Japan by the year end of 2022.

Market growth can be attributed to factors such as increased disease awareness, expanded recommendations by governmental and advisory bodies to be vaccinated against seasonal influenza, introduction of quadrivalent influenza vaccines, increase in the size of the elderly population in most countries. The barriers limiting the growth of the influenza market include limited patient awareness regarding the threat of influenza and the importance of influenza vaccinations, high investment and strict regulations act as barriers for new entrants.

The United States seasonal influenza vaccine market is the most attractive of those covered in the report. The United States market for seasonal influenza vaccine is expected to grow at a CAGR of XX% and is expected to reach at US$ XXX Million by the end of the forecasted period. United Kingdom will be the second–largest market for seasonal influenza vaccine which is expected to grow at a CAGR of XX% by 2022. Germany is expected to be third largest seasonal influenza vaccine market being followed by Japan by the end of the forecasted period.

Further, prudent analysis has been done on the competitor’s part, where three major players grab major share of the seasonal influenza vaccine market by revenue. Sanofi Pasteur, GlaxoSmithKline(GSK), Seqirus, AstraZeneca and Protein Sciences Corporation are the key influencers with their products in the seasonal influenza vaccine market. Other emerging players such as Novavax, Daiichi–Sankyo, Mitsubishi Tanabe Pharma, BiondVax Pharmaceuticals Ltd, and VaxInnate are making novel technology based influenza vaccine which is likely to affect the market share during the forecast period.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry–validated market data. It also contains projection using a suitable set of assumptions and methodologies. It provides essential insights into seasonal influenza vaccine sales forecasts for the top seven countries, comprising the US, the UK, France, Italy, Spain, Germany and Japan until 2022. It also covers vaccination patterns and geographic distribution and offers a clear view of the regulatory landscape. Additionally, the report includes assessment of clinical trials, pipeline and promising vaccines in seasonal influenza vaccine market. Key trends in terms of M&A, collaborations and licensing agreements are analyzed with details. The report concludes with the profiles of major players in the seasonal influenza vaccine market such as Sanofi Pasteur, GSK, Sequirus, AstraZenecca and Protein Sciences Corporation. The major market players are evaluated on various parameters such as company overview, product outlook, and sales analysis of seasonal influenza vaccine market from 2011 to 2022. The report also entails major drivers and barriers of seasonal influenza vaccine market.

Seven Major Markets(7MM) covered in the report are as follows:


1. United States
2. United Kingdom
3. France
4. Italy
5. Spain
6. Germany
7. Japan


Major and Promising Vaccines covered in the report are as follows:


1. Fluzone High–Dose
2. Fluzone Quadrivalent
3. Intradermal (ID) Trivalent
4. Vaxigrip
5. Fluarix Quadrivalent
6. Flulaval Quadrivalent
7. Fluenz Tetra
8. FluMist Quadrivalent
9. Flublok
10. VN–100
11. M–001
12. VAX–2012Q
13. TAK – 850
14. Flucelvax Quadrivalent
15. Afluria Quadrivalent
16. Agrippal
17. Fluad
18. Fluvirin
19. Fluvax

Seasonal Influenza Vaccine Report is segmented with 10 Chapters:

Chapter 1: Chapter one is the introduction with Executive Summary

Chapter 2: Chapter two provides overall recent and forecasts data for the seasonal influenza vaccine market in the top seven countries. This Chapter divided into 4 parts

1. Overall seasonal influenza vaccine market data from 2010 to 2022
2. Overall number of persons vaccinated with seasonal influenza vaccine data from 2010 to 2022
3. Seasonal influenza vaccine market share in the top seven countries data from 2010 to 2022
4. Persons being vaccinated with influenza vaccine share in the top seven countries data from 2010 to 2022

Chapter 3: Key market drivers and barriers in the seasonal influenza vaccine market.

Chapter 4: Chapter four gives detailed recent and forecasts for the seasonal influenza vaccine markets in the US, the UK, France, Italy, Spain, Germany and Japan, comprising of market size, total number of persons vaccinated, number of children vaccinated, number of 60+ years of age persons vaccinated, number of pregnant women vaccinated, number of chronic medical condition persons vaccinated, number of healthcare workers vaccinated and vaccination coverage.

Chapter 5: Chapter five gives detailed information on seasonal influenza vaccine production & distribution in United States. The information includes vaccine choices remain available for patients, providers, prices of a dose of vaccine, production, supply, and allocation by the major seasonal influenza vaccine manufacturers, seasonal influenza vaccine distribution & demand, seasonal influenza vaccine effectiveness, managing influenza with diagnostic resources, distribution method of seasonal influenza vaccination.


Chapter 6: Chapter six offers information about regulatory landscape including the approval process and an overview of the regulatory authorities in the United States, EU and Japan.

Chapter 7: Chapter seven highlights key M&A deals that took place in the seasonal influenza vaccine market between 2003 and 2015 and lists the major collaborations, licensing, exclusive and distribution agreements deals.

Chapter 8: Chapter eight provides detailed pipeline influenza vaccines in various companies’ pipelines with clinical development and early stage development vaccines.

Chapter 9: Chapter nine offers detailed information of the recruiting clinical trials statement by phase, trial status, study sponsor name and study phase.

Chapter 10: Chapter ten gives information on the key players in the market with business overview, product outlook and sales analysis of the seasonal influenza vaccine.

"

Published

Read more
Kidney Transplant Market by Country (United States, Germany, France, Italy, United Kingdom, Japan, Argentina, Mexico, Spain, Brazil) Analysis and Forecast to 2021

Kidney transplant is the most commonly conducted transplant surgery worldwide. It has gained widespread popularity by improving the outcome of end-stage renal disease (ESRD) patients. With advances in kidney transplant methods and improvement in transplant success, a kidney transplant is now widely considered to be the best way of treating chronic kidney disease for many people. As the number of organ donors is increasing, an increase in transplant procedures is bound to happen. However, due to costlier procedure the market shift is expected to occur in Asian countries where medical tourism is being promoted.

Kidney Transplant Performed Analysis: United States is the leading kidney transplant performed with more than 40% share in 2015. The number of Kidney transplant done in 10 countries covered in the report was more than 40 Thousand in 2015. Brazil is the second leading kidney transplant performed country with more than 10% share. United Kingdom stands at the 3rd position in kidney transplant number. France and Mexico stand at the 4th and 5th place respectively in 2015.

Kidney Transplant Market Analysis: United States is the leading market for kidney transplant in 10 countries covered being followed by France. Spain stands at the 3rd position followed by Germany. Japan and Italy are competing very closely with each other to capture the maximum market share.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry–validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides the number of kidney transplant, as well as market and market shares of Kidney Transplant market. The report entails major organ transplant (immunosuppressant) drug sales analysis. This report also covers key development, drivers and challenges of Kidney Transplant market.

The 10 countries covered in the report are analysed from two viewpoints:

1. Number of Kidney Transplant Performed (2008 - 2021)
2. Kidney Transplant Market (2008 - 2021)


Based on geographical distribution, the Kidney Transplant market is categorized into following sub-markets:

1. United States
2. Germany
3. France
4. Italy
5. United Kingdom
6. Japan
7. Argentina
8. Mexico
9. Spain
10. Brazil

Organ Transplantation Immunosuppressive/Rejection Drugs Analysis in the report are as follows

1. Cellcept (Mycophenolate Mofetil)
2. Prograf(Tacrolimus)
3. Rapamune (Sirolimus)
4. Myfortic (Mycophenolic Acid)
5. Neoral / Sandimmune (Cyclosporine)
6. Zortress / Certican (Everolimus)

 

Published

Read more
Global Cell and Tissue Culture Supplies Sales Market Report 2025

In this report, the global Cell and Tissue Culture Supplies market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Cell and Tissue Culture Supplies for these regions, from 2013 to 2025 (forecast), covering
United States
China
Europe
Japan
Southeast Asia
India

Global Cell and Tissue Culture Supplies market competition by top manufacturers/players, with Cell and Tissue Culture Supplies sales volume, Price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
Stemcell Technologies
Wheaton Industries
GE Healthcare
Thermo Fisher Scientific
VWR International
Merck KGaA
Lonza Group
Corning
Promocell GmbH
Eppendorf AG

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Consumable Products
Instruments

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Vaccine Production
Biopharmaceutical Production
Toxicity Testing
Gene Therapy
Drug Screening & Development
Cancer Research
Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Published

Read more
Global Cancer Antibody Drug Conjugates Sales Market Report 2018

In this report, the global Cancer Antibody Drug Conjugates market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Cancer Antibody Drug Conjugates for these regions, from 2013 to 2025 (forecast), covering
United States
China
Europe
Japan
Southeast Asia
India

Global Cancer Antibody Drug Conjugates market competition by top manufacturers/players, with Cancer Antibody Drug Conjugates sales volume, Price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including
Novartis
Merck
Roche
AbbVie
UCB
Bristol-Myers Squibb
Stem CentRx
Biogen Idec
Nordic Nanovector
Millennium
Biotest AG
PDL BioPharma
Progenics Pharmaceuticals
Seattle Genetics
Viventia Biotechnologies
AbGenomics Corporation
Helix BioPharma
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
First & Second Generation ADCs
Third Generation ADCs

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Hospitals
Clinics
Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Published

Read more
Glutathione Market Report by Company, Regions, Types and Applications, Global Status and Forecast to 2025

This report studies the Glutathione market status and outlook of global, from angles of players, regions, product types and end industries; this report analyzes the top players in global market, and splits the Glutathione market by product type and application/end industries.

The global Glutathione market was XX million US$ in 2017 and is expected to XX million US$ by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Glutathione in these regions, from 2013 to 2025 (forecast), covering
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia and Turkey etc.)
Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia (Indonesia, Thailand, Philippines, Malaysia and Vietnam))
South America (Brazil etc.)
Middle East and Africa (North Africa and GCC Countries)

The major companies in this report including
Kyowa Hakko Bio
Shandong Jincheng Biological Pharmaceutical
KOHJIN Life Sciences
Shenzhen GSH Bio-tech
Kaiping Genuine Biochemical Pharmaceutical

By the product type, the market is primarily split into
Glutathione Reduced
Glutathione Oxidized

By the end users/application, this report covers the following segments
Pharmaceuticals
Health Products
Cosmetics
Food
Other

Published

Read more
Antiviral Drugs Market Global Size, Status and Forecast 2025

This report studies the global Antiviral Drugs market, analyzes and researches the Antiviral Drugs development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like
AbbVie
Bristol-Myers Squibb Company
Cipla
F. Hoffmann-La Roche
Gilead Sciences
GlaxoSmithKline
Johnson & Johnson
Merck
Mylan
Teva Pharmaceutical Industries

Market segment by Regions/Countries, this report covers
United States
EU
Japan
China
India
Southeast Asia

Market segment by Type, the product can be split into
Branded Drugs
Generic Drugs

Market segment by Application, Antiviral Drugs can be split into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

If you have any special requirements, please let us know and we will offer you the report as you want.

Published

Read more
Cosmetic Implant Market Global Research Report 2025

In this report, the global Cosmetic Implant market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Cosmetic Implant in these regions, from 2013 to 2025 (forecast), covering
North America
Europe
China
Japan
Southeast Asia
India

Global Cosmetic Implant market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
Aesthetic and Reconstructive Technologies (AART) Inc.
3M Health Care
DENTSPLY International Inc.
Allergan, Inc.
GC Aesthetics
Implantech Associates Inc.
Mentor Worldwide LLC
Institut Straumann AG
Sientra Inc.
Nobel Biocare Holding AG
Zimmer Holdings Inc
Spectrum Designs Medical

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Polymers
Ceramics
Metals
Biological Material

On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
Dental Implants
Breast Implants
Facial Implants
Penile Implants
Buttock Implants
Calf Implants

If you have any special requirements, please let us know and we will offer you the report as you want.

Published

Read more

SORT BY PRICE







REPORT TYPE

  • USA Office

    244 , Madison Avenue
    New York City, NY - 10016
    United States


    UK Office

    109 ,Straford Street,Leeds
    West Yorkshrie LS11 6JG
    United Kingdom

Copyright © 2018-19 futuregenicreports.com. All rights reserved.